Recurrent Chest Infections
Repeated lower respiratory tract infections in children, often defined as three or more episodes per year, warranting investigation for underlying causes such as asthma, immunodeficiency, cystic fibrosis, or structural airway abnormalities.
Recurrent chest infections (also called recurrent pneumonia when referring to lower respiratory tract involvement) in paediatrics is defined as ≥2 episodes of pneumonia in a single year, or ≥3 episodes at any time, with radiographic clearing between episodes [1][2]. This is a critical distinction — the chest X-ray must normalise between episodes to confirm that each is a new event rather than a single non-resolving infection.
The term "recurrent chest infections" is broader and may encompass recurrent lower respiratory tract infections (LRTIs) including pneumonia, bronchitis, and bronchiolitis, particularly when a child presents repeatedly with cough, fever, and respiratory distress requiring medical attention.
Why does this matter? A child with "unresolving pneumonia" (persistent CXR changes) has a different differential diagnosis (e.g., foreign body, congenital pulmonary airway malformation, TB) from one with true recurrent infections (where clearing between episodes points towards host susceptibility — immune deficiency, aspiration, structural anomaly, or ciliary dysfunction).
Key Definition
Recurrent pneumonia = ≥2 episodes/year OR ≥3 episodes ever, with radiographic clearing in between. If the CXR never clears, think non-resolving pneumonia — a different workup entirely.
Epidemiology
8 to 10 URTIs per year in young children can be normal, provided there is no end-organ damage [3]. This is especially true for children:
Recurrent infections are common in childhood. Infections in healthy children are usually: of short duration, self-limited, uncomplicated, and the child is healthy in between episodes [3].
The majority (~50%) of children with recurrent infections are normal and healthy [1]. Risk factors for frequent but normal infections include daycare/school attendance, older siblings, exposure to passive smoke, and the natural immaturity of the developing immune system.
- Recurrent pneumonia accounts for roughly 6–9% of all childhood pneumonia cases
- It is more common in children < 5 years (immature immune system, smaller airways, higher exposure)
- In Hong Kong, respiratory infections remain a major cause of paediatric hospitalisation
- Boys are slightly more affected than girls (reflecting the slight male predominance in childhood respiratory disease and asthma)
| Category | Examples |
|---|---|
| Age | Young children (< 5y) — immature adaptive immunity, smaller airways |
| Environmental | Daycare attendance, crowded living (HK high-density housing), passive tobacco smoke, air pollution |
| Atopy/Asthma | Underlying asthma with airway inflammation and mucus hypersecretion |
| Nutritional | Malnutrition, micronutrient deficiency (zinc, vitamin A) |
| Anatomical | Congenital lung malformations, vascular rings, tracheo-oesophageal fistula |
| Neurological | Cerebral palsy, bulbar dysfunction → aspiration |
| Immunodeficiency | Primary (inborn errors of immunity) or secondary (HIV, nephrotic syndrome, immunosuppressants) |
| Genetic | Cystic fibrosis, primary ciliary dyskinesia |
Anatomy and Function — Why the Paediatric Airway Is Vulnerable
Understanding why children get recurrent chest infections requires appreciating the unique paediatric respiratory anatomy and immune physiology:
- Smaller airway calibre: Poiseuille's law tells us that resistance ∝ 1/r⁴. A 1mm reduction in radius in a child's already-small bronchiole causes a proportionally much greater increase in resistance (and therefore mucus trapping) than the same reduction in an adult.
- More compliant chest wall: The infant's rib cage is more cartilaginous and horizontally oriented → less effective cough generation → poorer secretion clearance.
- Relatively large tongue and adenoids: Contribute to upper airway obstruction and mouth breathing, bypassing the nasal filtering/warming/humidifying function.
- Shorter, more horizontal Eustachian tubes: Predispose to otitis media (relevant because sinopulmonary infections often co-occur).
The respiratory epithelium is lined with ciliated pseudostratified columnar epithelium. Cilia beat in a coordinated metachronal wave to propel mucus (with trapped pathogens and debris) upward toward the pharynx ("mucociliary escalator"). Any defect in:
- Cilia structure/function (primary ciliary dyskinesia) → stasis of secretions → bacterial colonisation → recurrent infection
- Mucus composition (cystic fibrosis — dehydrated, viscous mucus due to CFTR dysfunction) → impaired clearance → chronic infection
- Mucosal integrity (post-viral damage, chronic inflammation) → reduced clearance
- Maternal IgG crosses the placenta and provides passive protection for the first ~4–6 months of life, then wanes
- IgA (the dominant mucosal immunoglobulin) does not reach adult levels until ~6–8 years
- T cell function is relatively naive in infancy; thymic output is maximal in early childhood but the repertoire is limited
- This means that the period from 6 months to ~5 years is a physiological "window of vulnerability" for infections — and this is precisely when primary immunodeficiencies (especially antibody deficiencies) tend to declare themselves
| Level | Mechanism | Failure → |
|---|---|---|
| Mechanical | Cough reflex, epiglottic closure, mucociliary clearance | Aspiration, mucus stasis |
| Innate | Alveolar macrophages, neutrophils, complement, surfactant proteins (SP-A, SP-D) | Phagocyte defects, complement deficiency |
| Adaptive | Secretory IgA, IgG in alveolar lining fluid, T cell surveillance | Antibody deficiency, combined immunodeficiency |
Aetiology (Focus on Hong Kong)
The causes of recurrent chest infections in children can be systematically divided. A useful framework is:
A. Non-Immunologic Defects
These are structural, mechanical, or functional problems that impair local lung defence without affecting the systemic immune system.
Obstruction to flow [1]:
- Bronchial obstruction → recurrent pneumonia of the same lobe [1]
- Eustachian tube obstruction → recurrent otitis media [1]
| Cause | Mechanism | Clinical Clue |
|---|---|---|
| Foreign body aspiration | Partial obstruction → ball-valve effect → distal air trapping, atelectasis, post-obstructive pneumonia | Sudden onset cough/wheeze in a toddler, recurrent pneumonia in same lobe (classically RLL or RML due to the more vertical right main bronchus) |
| Congenital pulmonary airway malformation (CPAM) | Abnormal cystic/solid lung tissue that does not participate in gas exchange; acts as nidus for infection | Recurrent infections in same region; prenatal USS may show lesion |
| Pulmonary sequestration | Aberrant lung tissue with systemic arterial supply, no connection to tracheobronchial tree (intralobar) or its own pleural covering (extralobar); acts as "dead space" | Recurrent LLL pneumonia, often with air-fluid levels on imaging |
| Vascular ring/sling | Anomalous great vessels compress trachea/bronchi | Stridor, feeding difficulties, recurrent wheeze/infections |
| Mediastinal lymphadenopathy | TB (very relevant in HK), lymphoma → extrinsic bronchial compression | Persistent cough, weight loss, contact history |
| Bronchial stenosis / bronchomalacia | Congenital narrowing or excessive airway collapse → distal mucus trapping | Persistent wheeze, recurrent infections in same territory |
Hong Kong context: Foreign body aspiration (peanuts, small toy parts) is an important and treatable cause — always ask about choking episodes. TB-related mediastinal lymphadenopathy causing bronchial compression is also relatively more common in HK than in many Western countries.
Inadequate clearance [1]:
- Primary ciliary dyskinesia (PCD) → bronchiectasis [1]
Abnormal mucus production [1]
| Cause | Mechanism |
|---|---|
| Primary ciliary dyskinesia (PCD) | Autosomal recessive; abnormal ciliary ultrastructure (dynein arm defects) → immotile or dyskinetic cilia → failed mucociliary clearance. ~50% have Kartagener syndrome (situs inversus + chronic sinusitis + bronchiectasis) [2] |
| Cystic fibrosis (CF) | CFTR mutation → defective Cl⁻ channel → dehydrated, viscous airway surface liquid → impaired mucociliary clearance → chronic infection [2] |
CNS abnormalities → recurrent aspiration [1]
| Cause | Mechanism | Clinical Clue |
|---|---|---|
| Neurodevelopmental disorders (cerebral palsy, global developmental delay) | Poor oromotor coordination, impaired swallow reflex, poor airway protection | Cough/choking with feeds, feeding difficulties [4], recurrent RLL pneumonia |
| Gastro-oesophageal reflux disease (GORD) | Acid + particulate reflux → aspiration, especially during sleep | Vomiting, irritability, poor weight gain in infants; chronic cough, recurrent wheeze |
| Tracheo-oesophageal fistula (TOF/TEF) | Abnormal connection between trachea and oesophagus → feeds enter airway | Recurrent pneumonia [4]; usually diagnosed in neonatal period but H-type fistula may present late |
| Laryngeal cleft | Defect in posterior cricoid cartilage → aspiration | Stridor, feeding difficulties, chronic cough |
| Cleft palate (submucous) | Impaired velopharyngeal closure → nasopharyngeal reflux and aspiration | Nasal regurgitation, chronic cough |
Foreign body (including VP shunt, prosthetic valve, central line, indwelling catheter) [1] — these act as nidi for biofilm formation and recurrent infection.
Damaged barrier [1]:
- Burn, sinus tract, open fracture → pyogenic infection
- Midline/middle ear defect → recurrent meningitis
In the context of recurrent chest infections, consider congenital dermal sinuses communicating with the airway (rare) or chest wall defects post-surgery.
Secondary immunodeficiencies (e.g., HIV, measles, chemo, cancer, malnutrition) [3]
| Cause | Mechanism | HK Relevance |
|---|---|---|
| Malnutrition | Impaired cell-mediated immunity, reduced secretory IgA, complement dysfunction | Less common in HK but seen in neglect, chronic illness, eating disorders |
| HIV | CD4+ T cell depletion → opportunistic infections | Rare in HK paediatrics but must be considered; vertical transmission possible |
| Nephrotic syndrome | Urinary loss of IgG and complement factor B → susceptibility to encapsulated bacteria | Relevant — nephrotic syndrome is not uncommon in HK children |
| Iatrogenic | Corticosteroids, immunosuppressants, chemotherapy, post-splenectomy | Children on chronic steroids for asthma/nephrotic syndrome; post-splenectomy for haematological disorders |
| Post-measles | Measles virus causes transient but profound immunosuppression ("immune amnesia") for weeks-months | Measles outbreaks still occur; relevant in under-vaccinated children |
| Malignancy | Leukaemia/lymphoma → bone marrow infiltration → pancytopenia; solid tumours → cachexia | Always consider if recurrent infections + systemic symptoms (weight loss, pallor, bruising) |
C. Primary Immunodeficiency (Inborn Errors of Immunity, IEI)
Primary immunodeficiencies (i.e., inborn errors of immunity) [3]
Now referred to as inborn errors of immunity (IEI) [1]. There are > 440 different diseases, occurring in ~1/4000 births (i.e., rare disease) [1].
The pattern of infections gives a strong clue to which arm of the immune system is defective:
Commonly cause sinopulmonary and GI infections — because (1) sites where most Ig deposits, (2) open to external environment [1]
Timing: present after 4–6 months due to maternal IgG depletion [1]
Common pathogens: encapsulated bacteria, Giardia, enterovirus [1]
| Condition | Genetics | Pathophysiology | Key Features |
|---|---|---|---|
| X-linked (Bruton) agammaglobulinaemia (XLA) | XLR | Abnormal Bruton tyrosine kinase (Btk) gene → essential for all stages of B cell development → ↓B cell maturation [1] | ↓B cells, pan-hypo(γ)globulinaemia (hence absent tonsils, and immunisation being useless!) [1]; recurrent sinopulmonary infections since 6 months of age [3]; CT showing sinusitis, HRCT showing bronchiectasis [3] |
| Common variable immunodeficiency (CVID) | Variable | Impaired B cell differentiation → defective Ig production [1] | Most common form of severe antibody deficiency [1]; ↓↓↓IgG, ↓IgA/E; recurrent infections, autoimmune disease, malignancy [1] |
| Hyper IgM syndrome (HIGM) | XLR or AR | Failure to switch IgM to IgG/A [1] | ↑IgM, ↓IgG/A/E [1]; recurrent sinopulmonary infections + opportunistic infections (PJP) if CD40L type |
| Selective IgA deficiency | Variable | Isolated deficiency of IgA | Most common PID; usually asymptomatic, may occasionally present with recurrent infections [1] |
Why sinopulmonary? The respiratory and GI tracts are the body's largest mucosal surfaces in direct contact with the outside world. Secretory IgA is the first line of adaptive mucosal defence. When antibody production fails, these surfaces become the primary battleground.
Commonly cause severe ± unusual viral and fungal infections [1]
Examples: severe bronchiolitis, oral thrush, PJP, disseminated CMV infection [1]
| Condition | Pathophysiology | Key Features |
|---|---|---|
| Severe combined immunodeficiency (SCID) | Heterogeneous group with impaired B and T cell development [1] | Fatal without treatment; present with FTT, recurrent severe infections; ↓ALC, absent thymus shadow on CXR [1] |
| Wiskott-Aldrich syndrome (WAS) | WASp gene mutation → defective actin cytoskeleton in haematopoietic cells | Triad: immunodeficiency + thrombocytopenia + eczema [1] |
| DiGeorge syndrome | 22q11.2 deletion → defective pharyngeal pouch development → hypoplastic thymus [1] | Triad: conotruncal cardiac anomalies + hypoplastic thymus (T cell deficiency) + hypoplastic parathyroid (hypoCa) [1] |
| Ataxia telangiectasia | ATM gene mutation → defective DNA repair | Cerebellar ataxia, developmental delay, ↑risk of lymphoma [1] |
Commonly cause recurrent bacterial infections; common pathogens: skin commensals, fungi [1]
| Condition | Pathophysiology | Key Features |
|---|---|---|
| Chronic granulomatous disease (CGD) | Phagocytes fail to produce superoxide → inability to destroy microbes (especially catalase-positive) [1] | Recurrent pyogenic infections with granuloma formation; common sites: lung, skin, LNs, liver; lymphadenitis, hepatosplenomegaly, skin/perianal abscess, TB/BCG dissemination [1] |
| Leukocyte adhesion deficiency (LAD) | Deficiency of neutrophil surface adhesion molecule (CD18) → inability to leave vasculature [1] | ↑neutrophil count (trapped inside vessel); poor wound healing with absent pus formation; omphalitis with delayed umbilical cord separation [1] |
Why catalase-positive organisms in CGD? Normal neutrophils use the NADPH oxidase system to generate superoxide → hydrogen peroxide to kill bacteria. Catalase-negative bacteria (e.g., Streptococcus) actually produce their own H₂O₂, which the neutrophil can "borrow" to kill them even without a working oxidative burst. But catalase-positive organisms (Staphylococcus, Aspergillus, Serratia, Nocardia, Burkholderia — mnemonic: "SANK B") destroy their own H₂O₂ with catalase, so CGD neutrophils have no backup mechanism.
Commonly cause recurrent bacterial infections and SLE-like illness; common pathogens: encapsulated bacteria [1]
| Deficiency | Consequence |
|---|---|
| Early classical pathway (C1, C2, C4) | SLE-like illness (impaired immune complex clearance) + recurrent infections with encapsulated bacteria |
| C3 | Severe recurrent pyogenic infections (C3 is central to all three complement pathways) |
| Terminal pathway (C5–C9) | Recurrent Neisseria (meningococcal/gonococcal) infections — MAC formation is essential for killing Neisseria |
| Mannose-binding lectin (MBL) | Recurrent infections in early childhood (common, usually mild) |
| Cause | Mechanism | Notes |
|---|---|---|
| Asthma (poorly controlled) | Chronic airway inflammation, mucus plugging, corticosteroid use (local immunosuppression), airway remodelling | Most common chronic respiratory disease in HK children [2]; sometimes "recurrent pneumonia" may merely reflect frequent URTI or asthma [3] |
| Tuberculosis | Can mimic or cause recurrent pneumonia via endobronchial disease, lymph node compression, cavitation | HK is intermediate-endemic; always consider |
| Congenital heart disease | Pulmonary overcirculation (L→R shunts: VSD, ASD, PDA) → pulmonary oedema → impaired gas exchange and clearance → recurrent LRTIs | Very relevant to paediatrics |
| Bronchiectasis (established) | Dilated, damaged airways → impaired clearance → chronic colonisation → recurrent exacerbations | End-result of many of the above causes |
Regardless of the underlying aetiology, recurrent chest infections share a common final pathway — Cole's "vicious cycle" hypothesis of bronchiectasis:
This explains why early identification and treatment of the underlying cause is critical — once the cycle is established, bronchiectasis becomes irreversible.
Classification
| Pattern | Interpretation | Likely Causes |
|---|---|---|
| Same lobe every time | Recurrence in the same region → look for anatomical anomalies and RFs for aspiration [5] | Foreign body, bronchial stenosis, CPAM, sequestration, extrinsic compression (LN, tumour, vascular ring) |
| Different lobes each time | Recurrence in different regions → look for underlying systemic factors [5] | Immunodeficiency, PCD, CF, aspiration, asthma |
| Mechanism | Examples |
|---|---|
| Structural/anatomical | Foreign body, CPAM, sequestration, vascular ring, bronchial stenosis, bronchomalacia |
| Impaired clearance | PCD, CF, bronchiectasis |
| Recurrent aspiration | GORD, neurodevelopmental disorders, TOF, laryngeal cleft |
| Immune deficiency | Primary (IEI) or secondary |
| Airway inflammation | Asthma, allergic bronchopulmonary aspergillosis (ABPA) |
| Increased pulmonary blood flow | Congenital heart disease with L→R shunt |
IUIS PID classification [1]:
- Combined immunodeficiency (CID)
- CID with associated/syndromic features
- Humoral (Ab) deficiency
- Immune dysregulation
- Phagocyte defect
- Intrinsic and innate immunity
- Autoinflammatory disorder
- Complement deficiency
- Bone marrow failure
- Phenocopies of PID
Clinical Features
Symptoms
The clinical presentation depends on the underlying cause, but the presenting complaint is almost always cough — and the character of that cough is highly informative.
| Symptom | Pathophysiological Basis | Suggests |
|---|---|---|
| Daily moist/productive cough [4] | Active airway secretion/pus production from chronic bacterial infection of damaged airways | Suppurative lung disease [4] — bronchiectasis, CF, PCD |
| Paroxysmal cough with whooping | Post-tussive vomiting from forceful cough against closed glottis | Pertussis, post-infectious cough |
| Dry cough worse at night | Vagal-mediated bronchoconstriction in recumbent position; post-nasal drip | Asthma, GORD |
| Cough with feeds/immediately after eating | Aspiration of food/liquid into airway stimulating cough reflex | Aspiration (TOF, GORD, swallowing dysfunction) |
| Barking/croupy cough | Subglottic inflammation/oedema | Recurrent croup (consider subglottic stenosis or haemangioma if truly recurrent) |
| Chronic cough with copious purulent sputum ± haemoptysis | Bronchial wall destruction with erosion into bronchial arteries | Bronchiectasis (CF, PCD, post-infectious) |
| Symptom | Basis |
|---|---|
| Recurrent fever | Inflammatory response to pulmonary infection; cytokine release (IL-1, IL-6, TNF-α) resets hypothalamic set point |
| Tachypnoea/dyspnoea | V/Q mismatch from consolidation/atelectasis → hypoxaemia → chemoreceptor-driven respiratory drive |
| Wheeze [4] | Intrathoracic airway lesion (e.g., asthma, foreign body) [4]; turbulent airflow through narrowed airways |
| Chest tightness | Bronchospasm, pleural inflammation |
| Chest pain [4] | Arrhythmia, asthma, increased respiratory distress (parenchymal disease) [4] |
| Haemoptysis | Erosion of inflamed/damaged airway wall into hypertrophied bronchial arteries (especially in bronchiectasis) |
| Symptom | Basis |
|---|---|
| Failure to thrive / poor weight gain [4] | Serious systemic including pulmonary illness [4]; increased metabolic demand from chronic infection + poor intake + malabsorption (if CF) |
| Feeding difficulties [4] | Serious systemic including pulmonary illness, aspiration [4] |
| Chronic diarrhoea / steatorrhoea | Pancreatic exocrine insufficiency (CF) or GI infections (antibody deficiency — Giardia) |
| Recurrent otitis media / sinusitis | Shared mucosal immune deficiency (IgA deficiency, XLA, PCD); Eustachian tube dysfunction |
| Persistent thrush after age 1 [3] | T cell / combined immunodeficiency — Candida is normally controlled by cell-mediated immunity |
| Recurrent skin abscesses | Phagocyte defect (CGD, LAD) or Hyper-IgE syndrome |
| Easy bruising / petechiae | Wiskott-Aldrich syndrome (thrombocytopenia); leukaemia |
10 warning signs of IEI (Jeffrey Modell Foundation) [3]:
- Eight or more new ear infections within 1 year
- Two or more serious sinus infections within 1 year
- Two or more months on antibiotics with little effect
- Two or more pneumonias within 1 year
- Failure of an infant to gain weight or grow normally
- Recurrent, deep skin or organ abscesses
- Persistent thrush in mouth or elsewhere on skin, after age 1
- Need for intravenous antibiotics to clear infections
- Two or more deep-seated infections
- A family history of IEI
Not a comprehensive list — do not exclude patients based on 10 warning signs. Patients could present with non-infectious phenotypes [3].
Note: Any rare immunological phenomenon can have a monogenic basis (i.e., be an IEI). Some patients may present without a history of recurrent or opportunistic infections [3].
Exam Pearl
Sometimes "recurrent pneumonia" may merely reflect frequent URTI or asthma [3]. Always confirm with CXR that there was genuine parenchymal disease with clearing between episodes before launching into an extensive immunodeficiency workup.
Signs
| Sign | Pathophysiological Basis | Suggests |
|---|---|---|
| Digital clubbing [4] | Chronic suppurative lung disease [4]; mechanism debated but likely involves megakaryocyte fragments bypassing the pulmonary capillary filter (due to R→L shunting or bronchial-pulmonary anastomoses) → platelet-derived growth factor (PDGF) release in nail bed | CF, bronchiectasis, chronic empyema, congenital heart disease |
| Chest wall deformity (Harrison's sulci, pectus carinatum, hyperinflation) [4] | Chronic airway or parenchymal disease [4]; chronic air trapping → hyperinflation → outward pressure on compliant paediatric thorax | Chronic asthma, CF, bronchiectasis |
| Crepitations (crackles) [4] | Parenchymal disease [4]; opening of collapsed alveoli or air bubbling through secretions/fluid | Consolidation, bronchiectasis, interstitial lung disease |
| Coarse inspiratory crackles | Airway secretions in large/medium airways | Bronchiectasis, CF |
| Fine end-inspiratory crackles | Alveolar disease (fluid/fibrosis) | Interstitial lung disease, pulmonary oedema |
| Wheeze (expiratory) | Narrowed intrathoracic airways oscillating during expiration | Asthma, foreign body (unilateral), CF |
| Stridor (inspiratory) | Narrowed extrathoracic/upper airway | Vascular ring, subglottic stenosis, laryngomalacia |
| Unilateral reduced air entry | Lobar collapse, effusion, or foreign body | Depends on context |
| Hypoxia/cyanosis [4] | Airway or parenchymal disease, cardiac disease [4]; V/Q mismatch or R→L shunt | Severe pneumonia, CHD, chronic lung disease |
| Sign | What It Suggests | Why |
|---|---|---|
| Absent tonsils / lymph nodes | XLA (Bruton agammaglobulinaemia) | No B cells → no lymphoid tissue development |
| Oral thrush (persistent, > 1 year) | T cell / combined immunodeficiency | Candida clearance depends on T cell immunity |
| Eczema + petechiae | Wiskott-Aldrich syndrome | Thrombocytopenia + immune dysregulation + eczema |
| Situs inversus (dextrocardia on examination) | Primary ciliary dyskinesia (Kartagener syndrome) | Embryonic ciliary motility determines L-R lateralisation; absent/dysfunctional cilia → 50% chance of situs inversus |
| Conotruncal cardiac murmur + dysmorphic facies | DiGeorge syndrome (22q11.2 deletion) | Defective pharyngeal pouch development → cardiac + thymic + parathyroid anomalies |
| Neurodevelopmental abnormality [4] | Aspiration lung disease [4] | Poor oromotor coordination → chronic aspiration |
| Hepatosplenomegaly + lymphadenopathy | CGD, malignancy, storage disorders | Granuloma formation (CGD) or infiltration (leukaemia/lymphoma) |
| Delayed umbilical cord separation | Leukocyte adhesion deficiency | Neutrophils cannot migrate out of vessels → cannot mediate cord separation (which requires local inflammation) |
| Perianal / skin abscesses | CGD, Hyper-IgE syndrome | Phagocyte dysfunction → inability to contain catalase-positive organisms |
| Nasal polyps (in a child) | CF, PCD | Chronic sinus inflammation; nasal polyps are unusual in children and should always prompt investigation |
| Poor growth / FTT | CF, immunodeficiency, chronic disease, malignancy | Increased metabolic demand ± malabsorption ± anorexia |
Clinical Pearl
A child with recurrent sinopulmonary infections + bronchiectasis + situs inversus = Primary Ciliary Dyskinesia (Kartagener syndrome) until proven otherwise. A child with recurrent sinopulmonary infections + steatorrhoea + clubbing = Cystic Fibrosis until proven otherwise. A child with recurrent sinopulmonary infections + absent tonsils + panhypogammaglobulinaemia presenting after 6 months = X-linked agammaglobulinaemia.
Past medical history: Document in detail any past medical concerns. Note IEIs can affect many different organs [3]:
- Infections (recurrent, opportunistic or live vaccine complications) [3]
- Autoinflammation, autoimmunity, e.g., IBD, AIHA, arthritis [3]
- Non-malignant lymphoproliferation [3]
- Atopy [3]
- Cancer, e.g., lymphoma [3]
Specific history points:
| Domain | Key Questions | Rationale |
|---|---|---|
| Infection history | How many episodes? Which lobes? Required IV antibiotics? ICU admissions? Organisms isolated? | Severity and pattern guide differential |
| Between episodes | Is the child completely well? Any chronic cough? | Well between → likely structural/intermittent; never fully well → chronic disease (CF, bronchiectasis, immunodeficiency) |
| Feeding/swallowing | Coughing/choking with feeds? Nasal regurgitation? Vomiting? | Aspiration aetiology |
| Growth | Plot height and weight on growth chart | FTT = red flag for chronic disease |
| Birth history | Prematurity (BPD)? Neonatal respiratory distress? Meconium ileus? Delayed cord separation? | CF (meconium ileus), LAD (delayed cord separation), CHD, TOF |
| Family history | Consanguinity? Deaths in infancy? Known immunodeficiency? CF carrier status? | AR conditions (CF, PCD, SCID, CGD) |
| Vaccination history | Any adverse reaction to live vaccines (BCG, OPV, MMR, varicella)? | Disseminated BCG → CGD or SCID; live vaccine complications = red flag for immunodeficiency |
| Medications | Chronic corticosteroids? Immunosuppressants? | Secondary immunodeficiency |
| Social/environmental | Daycare? Passive smoke? Pets? Housing conditions? TB contacts? | Environmental exposures |
When a child presents with recurrent chest infections, think systematically:
High Yield Summary
Recurrent chest infections in paediatrics:
-
Definition: ≥2 pneumonias/year or ≥3 ever, with CXR clearing between episodes.
-
Normal children can have 8–10 URTIs/year — this is usually benign if self-limiting and uncomplicated.
-
Three major categories of causes: Non-immunologic defects, secondary immunodeficiency, primary immunodeficiency (IEI).
-
Same-lobe recurrence → local/anatomical cause (foreign body, CPAM, sequestration, bronchial compression). Different-lobe recurrence → systemic cause (immune deficiency, CF, PCD, aspiration).
-
Antibody deficiencies are the most common PID (~36%); present after 4–6 months when maternal IgG wanes; cause sinopulmonary infections with encapsulated bacteria.
-
Combined immunodeficiencies (SCID) present early with severe, unusual, opportunistic infections and are fatal without treatment.
-
Phagocyte defects (CGD) → catalase-positive organism infections (Staph, Aspergillus, Serratia, Nocardia, Klebsiella, Burkholderia).
-
Key clinical clues: absent tonsils (XLA), situs inversus (PCD/Kartagener), persistent thrush (T cell deficiency), delayed cord separation (LAD), FTT + steatorrhoea (CF), eczema + thrombocytopenia (WAS).
-
10 Warning Signs of IEI (Jeffrey Modell Foundation) — not comprehensive but useful screening tool.
-
Always confirm genuine pneumonia with CXR — "recurrent pneumonia" may actually be recurrent URTI or poorly controlled asthma.
-
CF classical triad: ↑sweat Cl⁻ + recurrent lung infections + pancreatic insufficiency. PCD: chronic wet cough + chronic sinusitis ± situs inversus ± bronchiectasis.
-
Vicious cycle: Infection → inflammation → airway damage → impaired clearance → more infection → bronchiectasis (irreversible). Early diagnosis and treatment breaks this cycle.
Active Recall - Recurrent Chest Infections in Children
[1] Senior notes: Adrian Lui Pediatrics.pdf (p163, p167, p181, p183, p406, p410, p411) [2] Senior notes: Ryan Ho Respiratory.pdf (p65, p67, p129) [3] Lecture slides: GC 144. A child with recurrent infections Primary immunodeficiencies.pdf (p3, p4, p6, p12, p28) [4] Lecture slides: GC 141. A child with cough acute and chronic cough in children.pdf (p20) [5] Senior notes: Ryan Ho Respiratory.pdf (p67)
Differential Diagnosis of Recurrent Chest Infections in Children
Before diving into a list, let's establish the clinical reasoning. When a child presents with recurrent chest infections, your job as a clinician is to answer three sequential questions:
- Is this truly recurrent pneumonia? — Confirm genuine parenchymal disease with radiographic clearing between episodes. Sometimes "recurrent pneumonia" may merely reflect frequent URTI or asthma [3].
- Is the recurrence in the same anatomical location or different locations each time? — This single question splits the differential neatly into local vs. systemic causes [5].
- What is the pattern of infection? — The type of pathogen, severity, associated features, and age of onset point to specific aetiologies.
Why is anatomical pattern so important? If the same lobe is affected every time, something local is preventing that lobe from clearing properly (obstruction, malformation, aspiration into a gravity-dependent region). If different lobes are affected, the problem is systemic — the whole lung is vulnerable because the child's defences (immune, mucociliary, or protective reflexes) are globally impaired.
Systematic Differential Diagnosis Table
The table below organises differentials by mechanism, with distinguishing features and pathophysiological reasoning.
Recurrence in the same region → look for anatomical anomalies and RFs for aspiration [5]
| Differential | Pathophysiology | Key Distinguishing Features | Age Group |
|---|---|---|---|
| Foreign body aspiration | Partial obstruction → ball-valve mechanism → distal air trapping, atelectasis, and post-obstructive pneumonia. The foreign body also acts as a nidus for bacterial growth. Classically affects the right lung because the right main bronchus is wider, shorter, and more vertical. | Intrathoracic airway lesion (e.g., asthma, foreign body) → wheeze [4]; sudden-onset choking episode (often witnessed) in a toddler (peak 1–3 years); unilateral wheeze; recurrent pneumonia always in the same lobe (typically RLL or RML); CXR may show air trapping, mediastinal shift, atelectasis | 6 months – 4 years (peak) |
| Bronchial obstruction [1] | Intrinsic narrowing (stenosis) or excessive collapsibility (bronchomalacia) → mucus cannot drain from the distal lobe → post-obstructive infection | Recurrent pneumonia of same lobe [1]; persistent focal wheeze; may be congenital or acquired (post-intubation) | Any age |
| Extrinsic bronchial compression — mediastinal lymphadenopathy (TB, lymphoma), vascular ring/sling | Enlarged lymph nodes or anomalous vessels compress a bronchus from outside → same mechanism as endobronchial obstruction | TB: contact history, chronic cough, weight loss, night sweats (HK is intermediate-endemic); Lymphoma: constitutional symptoms, hepatosplenomegaly; Vascular ring: stridor, feeding difficulties from oesophageal compression | TB: any; Lymphoma: school-age; Vascular ring: infancy |
| Congenital pulmonary airway malformation (CPAM) | Abnormal cystic or solid lung tissue that does not participate in gas exchange and acts as a nidus for recurrent infection due to poor drainage and mucus pooling | Often detected on prenatal USS; recurrent pneumonia in same region; CT shows cystic/solid mass within lung parenchyma | Infancy onwards |
| Pulmonary sequestration | Aberrant non-functioning lung tissue with systemic arterial supply (from aorta, not pulmonary artery) and no normal bronchial connection (intralobar) → dead space that traps secretions | Recurrent LLL pneumonia (75% are intralobar, 60% in LLL); CT angiography shows anomalous feeding artery from aorta; may present with air-fluid level | Infancy–childhood |
| Localised bronchiectasis | Post-infectious destruction of bronchial wall in one region → permanently dilated airway with impaired clearance → chronic colonisation | History of a severe pneumonia (especially adenovirus, pertussis, measles, or TB) that damaged one area; persistent wet cough; HRCT confirms localised bronchiectasis | Post-infectious: any |
Exam Tip — Foreign Body
Always ask about a choking episode in any toddler with recurrent same-lobe pneumonia. Parents may have forgotten a brief episode months ago. A normal CXR does not exclude a foreign body — you may need inspiratory/expiratory films or fluoroscopy (looking for air trapping), or proceed straight to rigid bronchoscopy (both diagnostic and therapeutic).
B. Systemic Causes (Different-Lobe Recurrence)
Recurrence in different regions → look for underlying systemic factors [5]
| Differential | Pathophysiology | Key Distinguishing Features |
|---|---|---|
| Cystic fibrosis (CF) | CFTR mutation, AR inheritance [1] → defective chloride channel → dehydrated, viscous airway surface liquid → impaired mucociliary clearance → chronic/recurrent lung infections ± bronchiectasis [1]. Also affects pancreas, GI tract, sweat glands, vas deferens. | Classical triad: ↑sweat Cl⁻ + recurrent lung infections + pancreatic insufficiency [1]; common pathogens: S. aureus, H. influenzae (early), P. aeruginosa, Burkholderia cepacia (late) [1]; clubbing, chest hyperinflation, coarse inspiratory crackles ± expiratory wheeze [1]; steatorrhoea, FTT; nasal polyps in a child (unusual and should prompt CF testing); meconium ileus in neonates. Rare in Chinese but does occur [6]. |
| Primary ciliary dyskinesia (PCD) | AR inheritance; abnormal structure/function of cilia → ↓mucociliary clearance → recurrent respiratory infections [1]. During embryogenesis, ciliary beating determines left-right lateralisation; dysfunctional cilia → random situs (50% chance situs inversus). | ~50% have Kartagener syndrome (situs inversus + chronic sinusitis + bronchiectasis) [1]; chronic productive cough from birth/infancy; neonatal respiratory distress (unclear cause); chronic rhinosinusitis; chronic otitis media with effusion; recurrent productive cough, purulent nasal discharge, chronic ear infection [1]; male infertility (immotile sperm); screening with nasal NO (↓NO) [1] |
Why is nasal NO low in PCD? The paranasal sinuses are normally the major source of exhaled nasal NO. In PCD, chronic sinusitis and poor ventilation of the sinuses lead to trapped NO and reduced nasal NO concentrations. This makes it a useful screening test (but not diagnostic on its own).
CNS abnormalities → recurrent aspiration [1]
| Differential | Pathophysiology | Key Distinguishing Features |
|---|---|---|
| Neurodevelopmental disorders (cerebral palsy, global developmental delay, myopathies) | Poor oromotor coordination, weak cough, depressed swallow reflex → chronic micro-aspiration of saliva and feeds into the airway → chemical pneumonitis + bacterial superinfection | Neurodevelopmental abnormality → aspiration lung disease [4]; feeding difficulties → serious systemic illness, aspiration [4]; recurrent RLL pneumonia (gravity-dependent aspiration when upright) or bilateral lower lobes; wet/gurgling voice; cough/choking with feeds |
| Gastro-oesophageal reflux disease (GORD) | Reflux of acidic gastric contents past the upper oesophageal sphincter → laryngeal/tracheal aspiration → recurrent chemical injury + infection | Vomiting/regurgitation (but can be "silent" in infants); irritability with feeds; poor weight gain; apnoea in neonates; chronic cough worse when supine; CXR showing recurrent RLL or bilateral lower zone infiltrates |
| Tracheo-oesophageal fistula (TOF) | Abnormal connection between trachea and oesophagus → feeds enter the airway directly. Most types are diagnosed in the neonatal period, but H-type fistula (no oesophageal atresia) can present late with recurrent pneumonia [4] | Recurrent pneumonia [4]; choking/coughing with every feed since birth; recurrent unexplained pneumonia in an otherwise well infant; diagnosed by contrast swallow or bronchoscopy |
| Laryngeal cleft | Defect in the posterior cricoid lamina → communication between airway and oesophagus → aspiration during swallowing | Stridor, chronic cough, feeding difficulties; diagnosed on microlaryngoscopy/bronchoscopy |
Aspiration Pattern — Why RLL?
When a child aspirates while upright or semi-recumbent (i.e., during feeding), gravity directs aspirated material to the right lower lobe via the more vertical right main bronchus. When supine (e.g., during sleep), the posterior segments of the upper lobes and apical segments of the lower lobes are affected. This anatomical reasoning helps you localise the cause.
B3. Immune Deficiency
This is the category that exam questions love to test. The pattern of infection is the biggest clue to which arm of the immune system is defective.
Causes of recurrent infections [1]:
Primary immunodeficiency: genetically-determined defects in immunity. Now referred to as inborn errors of immunity (IEI). > 440 different diseases, ~1/4000 births [1].
| Immune Component Defect | Typical Infections | Typical Pathogens | Classic Examples | Key Distinguishing Features |
|---|---|---|---|---|
| Humoral (Ab) deficiency (36.3%) [1] | Sinopulmonary and GI infections [1]; bronchiectasis, granulomatous-lymphocytic ILD, IBD [1] | Encapsulated bacteria, Giardia, enterovirus [1] | XLA (absent B cells, panhypogammaglobulinaemia, absent tonsils) [1]; CVID (most common severe Ab deficiency, ↓↓↓IgG, ↓IgA/E) [1]; Hyper-IgM syndrome (↑IgM, ↓IgG/A/E) [1]; Selective IgA deficiency (most common PID, usually asymptomatic) [1] | Present after 4–6 months (when maternal IgG wanes) [1]; recurrent otitis media, sinusitis, pneumonia; may develop autoimmunity; CT showing sinusitis, HRCT showing bronchiectasis (as in XLA case) [3] |
| Combined (T + B cell) deficiency (19.8%) [1] | Severe ± unusual viral and fungal infections [1] | Opportunistic: PJP, CMV, Candida, adenovirus | SCID (fatal without treatment; ↓ALC, absent thymus on CXR) [1]; DiGeorge syndrome (22q11.2 del; conotruncal cardiac anomaly + thymic hypoplasia + hypoparathyroidism) [1]; Wiskott-Aldrich syndrome (eczema + thrombocytopenia + immunodeficiency) [1]; Ataxia telangiectasia (cerebellar ataxia, telangiectasia, ↑AFP, lymphoma risk) [1] | Present early in life; severe bronchiolitis, oral thrush, PJP, disseminated CMV [1]; FTT; complications from live vaccines (BCG → SCID, CGD; OPV → SCID, XLA) [1] |
| Phagocyte defect (14.9%) [1] | Recurrent bacterial infections; skin and deep organ abscesses | Skin commensals, fungi; catalase-positive organisms (CGD) | CGD (failure to produce superoxide → granuloma formation; lung/skin/LN/liver abscesses, BCG dissemination) [1]; LAD (↑neutrophil count, absent pus, delayed cord separation, omphalitis) [1] | Recurrent skin/perianal abscesses; lymphadenitis, hepatosplenomegaly [1]; non-healing wounds; abnormal DHR flow cytometry (CGD); absent CD18 (LAD) |
| Complement deficiency [1] | Recurrent bacterial infections and SLE-like illness [1] | Encapsulated bacteria [1]; especially Neisseria (terminal pathway deficiency) | Early component def (C1, C2, C4) → SLE-like; C3 def → severe pyogenic; C5–C9 def → recurrent Neisseria | SLE-like illness + recurrent infections; recurrent meningococcal disease; CH50 undetectable |
10 warning signs of IEI (Jeffrey Modell Foundation) [3]:
- Eight or more new ear infections within 1 year
- Two or more serious sinus infections within 1 year
- Two or more months on antibiotics with little effect
- Two or more pneumonias within 1 year
- Failure of an infant to gain weight or grow normally
- Recurrent, deep skin or organ abscesses
- Persistent thrush in mouth or elsewhere on skin, after age 1
- Need for intravenous antibiotics to clear infections
- Two or more deep-seated infections
- A family history of IEI
Not a comprehensive list — do not exclude patients based on 10 warning signs alone. Patients could present with non-infectious phenotypes [3].
Past medical history: Document in detail. Note IEIs can affect many different organs [3]:
- Infections (recurrent, opportunistic or live vaccine complications)
- Autoinflammation, autoimmunity, e.g., IBD, AIHA, arthritis
- Non-malignant lymphoproliferation
- Atopy
- Cancer, e.g., lymphoma
Note: Any rare immunological phenomenon can have a monogenic basis (i.e., be an IEI). Some patients may present without a history of recurrent or opportunistic infections [3].
Mnemonic for approach to PID infections — "SPUR": Serious, Persistent, Unusual, Recurrent [1] infections should trigger suspicion for immunodeficiency.
| Cause | Mechanism | Distinguishing Features |
|---|---|---|
| Iatrogenic (steroid, immunosuppressant, splenectomy) [1] | Drug-induced immune suppression or loss of splenic filtration function | Drug history; post-splenectomy → overwhelming post-splenectomy infection (OPSI) with encapsulated bacteria |
| Malnutrition [1] | Impaired cell-mediated immunity, reduced complement and secretory IgA; muscle wasting → respiratory muscle weakness → resp failure and chest infections [7] | Anthropometric evidence of wasting/stunting; micronutrient deficiencies |
| Nephrotic syndrome [1] | Urinary loss of IgG and complement factor B → susceptibility to encapsulated bacteria | Oedema, proteinuria, hypoalbuminaemia |
| HIV [1] | Progressive CD4+ T cell depletion → opportunistic infections | Consider in any child with unexplained recurrent infections; vertical transmission risk |
| Neoplasms [1] | Bone marrow infiltration (leukaemia) → pancytopenia; or chemotherapy-induced immunosuppression | Pallor, bruising, hepatosplenomegaly, lymphadenopathy, weight loss |
| Post-measles | "Immune amnesia" — measles virus destroys memory B and T cells → transient but profound susceptibility to infections for weeks to months | Recent measles illness; unvaccinated child |
| Differential | Pathophysiology | Key Distinguishing Features |
|---|---|---|
| L→R shunt CHD (VSD, ASD, PDA, AVSD) | Excessive pulmonary blood flow → pulmonary congestion and interstitial oedema → compression of small airways → impaired clearance + fluid in alveoli = culture medium → recurrent LRTIs | Cardiac murmur; signs of heart failure (tachypnoea, hepatomegaly, poor feeding, FTT, sweating with feeds); CXR showing cardiomegaly + pulmonary plethora; echocardiogram diagnostic |
Why does a VSD cause recurrent chest infections? The left-to-right shunt increases pulmonary blood flow. Engorgement of the pulmonary vasculature compresses the airways and increases interstitial fluid. The waterlogged lung cannot clear pathogens effectively, and the excess fluid provides a substrate for bacterial growth. Additionally, the child is often in heart failure with increased work of breathing and poor nutrition — further impairing immune function.
| Differential | Pathophysiology | Key Distinguishing Features |
|---|---|---|
| Poorly controlled asthma | Chronic eosinophilic airway inflammation → mucus hypersecretion, airway wall oedema, bronchospasm → mucus plugging → segmental atelectasis (which can mimic consolidation on CXR) → ± secondary bacterial infection | Is this an acute exacerbation of a chronic respiratory disorder? — Failure to thrive, finger clubbing, chest deformity, features of atopy [4]; episodic wheeze, nocturnal cough, triggers (allergens, exercise, cold air); Hx of atopy; responds to bronchodilators; CXR may show hyperinflation ± atelectasis (mimicking pneumonia!) |
| Allergic bronchopulmonary aspergillosis (ABPA) | IgE-mediated hypersensitivity to Aspergillus fumigatus colonising the airways → intense eosinophilic inflammation → mucoid impaction → proximal bronchiectasis | Usually in child with CF or severe asthma; peripheral eosinophilia; ↑total IgE ( > 1000 IU/mL); +ve Aspergillus-specific IgE and IgG; central bronchiectasis on HRCT (unique to ABPA) |
Don't Be Tricked by Asthma Mimicking Pneumonia
Sometimes "recurrent pneumonia" may merely reflect frequent URTI or asthma [3]. Mucus plugging in asthma can cause lobar/segmental atelectasis that looks exactly like consolidation on CXR. If a child with "recurrent pneumonia" always improves dramatically with bronchodilators and steroids rather than antibiotics, think asthma — not immunodeficiency. Always review the old CXRs carefully.
| Differential | Pathophysiology | Key Distinguishing Features |
|---|---|---|
| Tuberculosis | Can cause recurrent or non-resolving pneumonia; endobronchial TB or lymph node compression can cause post-obstructive pneumonia; miliary TB mimics recurrent pneumonia | Contact history; constitutional symptoms; TST/IGRA positivity; CXR: hilar lymphadenopathy, upper lobe predilection, miliary pattern; early morning gastric aspirate for AFB [8] |
| Bronchopulmonary dysplasia (BPD) | Chronic lung disease of prematurity → disrupted alveolar and vascular development → impaired gas exchange and clearance → recurrent infections | History of extreme prematurity ( < 28 weeks), prolonged NICU stay, mechanical ventilation; chronic oxygen dependency; CXR: cystic/fibrotic changes |
| Sickle cell disease | Functional asplenia → susceptibility to encapsulated bacteria; acute chest syndrome (vaso-occlusion + infection + fat embolism) mimics recurrent pneumonia | Haemolytic anaemia, pain crises, splenomegaly → later autosplenectomy; Hb electrophoresis diagnostic; less common in HK but seen in mixed-race families |
This is how you use clinical features to narrow the differential rapidly:
| Clinical Clue | Top Differentials |
|---|---|
| Recurrent pneumonia always same lobe | Foreign body, CPAM, sequestration, bronchial stenosis, extrinsic compression |
| Recurrent pneumonia + steatorrhoea / FTT | Cystic fibrosis |
| Recurrent pneumonia + situs inversus | Primary ciliary dyskinesia (Kartagener) |
| Recurrent pneumonia + absent tonsils + panhypogammaglobulinaemia | XLA |
| Recurrent pneumonia + eczema + thrombocytopenia | Wiskott-Aldrich syndrome |
| Recurrent pneumonia + cardiac murmur + FTT | CHD with L→R shunt |
| Recurrent pneumonia + choking with feeds | Aspiration (neurodevelopmental, TOF, GORD) |
| Recurrent pneumonia + deep organ abscesses + BCG dissemination | CGD |
| Recurrent pneumonia + delayed cord separation | LAD |
| Recurrent pneumonia + oral thrush > 1 year | T cell / combined immunodeficiency (SCID, DiGeorge) |
| Recurrent pneumonia + cardiac anomaly + hypocalcaemia | DiGeorge syndrome (22q11.2 del) |
| Recurrent RLL pneumonia in a neurologically impaired child | Aspiration |
| Recurrent pneumonia + atopic features, wheeze | Asthma (poorly controlled) |
| Recurrent pneumonia + no pathogen identified, subacute onset, contact history | Tuberculosis |
This is a crucial distinction in paediatrics — most children with recurrent infections are normal.
| Feature | Normal Child | Pathological (suspect underlying cause) |
|---|---|---|
| Frequency | 8–10 URTIs/year can be normal [3] | ≥2 pneumonias/year or ≥3 ever (with CXR clearing) [1] |
| Duration | Short duration, self-limited [3] | Prolonged; ≥2 months on antibiotics with little effect [3] |
| Severity | Uncomplicated [3] | Requiring IV antibiotics, ICU admission; deep-seated infections |
| Between episodes | Healthy in between episodes [3] | Ongoing symptoms (chronic cough, poor growth, persistent wheeze) |
| Growth | Normal | Failure to gain weight or grow normally [3] |
| Family history | Siblings in daycare, start of school [1] | Family history of IEI [3]; consanguinity; unexplained infant death |
| Organisms | Common viruses, typical bacteria | Opportunistic (PJP, CMV, Candida); unusual; catalase-positive |
| Response to treatment | Quick resolution | Poor or absent response |
High Yield Summary — Differential Diagnosis of Recurrent Chest Infections
Framework: Same lobe → local/anatomical; Different lobes → systemic.
Local causes: Foreign body (most treatable!), CPAM, pulmonary sequestration, bronchial stenosis/bronchomalacia, extrinsic compression (TB LN, vascular ring).
Systemic — Impaired clearance: CF (sweat Cl⁻ + steatorrhoea + lung infections), PCD (situs inversus + sinusitis + bronchiectasis).
Systemic — Aspiration: Neurodevelopmental disorders, GORD, TOF (H-type), laryngeal cleft.
Systemic — Immune deficiency: Primary (antibody deficiency most common — presents after 4–6 months; combined deficiency presents early and severely; phagocyte defects → catalase-positive organisms + abscesses; complement deficiency → Neisseria + SLE-like). Secondary (iatrogenic, malnutrition, HIV, nephrotic syndrome, malignancy).
Systemic — Cardiac: L→R shunt CHD → pulmonary overcirculation → recurrent LRTIs.
Systemic — Airway inflammation: Poorly controlled asthma (beware atelectasis mimicking consolidation), ABPA.
Differentiating normal from pathological: Normal children are well between episodes, grow normally, and respond to standard treatment. Red flags = SPUR infections (Serious, Persistent, Unusual, Recurrent), FTT, need for IV antibiotics, family history of IEI, live vaccine complications.
10 Warning Signs of IEI (Jeffrey Modell Foundation) — not comprehensive but a useful screening checklist.
Always confirm genuine pneumonia with CXR — "recurrent pneumonia" may be frequent URTI or asthma with atelectasis.
Active Recall - Differential Diagnosis of Recurrent Chest Infections
References
[1] Senior notes: Adrian Lui Pediatrics.pdf (p154, p163, p182, p406, p407, p410, p411) [3] Lecture slides: GC 144. A child with recurrent infections Primary immunodeficiencies.pdf (p3, p4, p6, p12, p28) [4] Lecture slides: GC 141. A child with cough acute and chronic cough in children.pdf (p15, p20) [5] Senior notes: Ryan Ho Respiratory.pdf (p67) [6] Senior notes: Ryan Ho Fundamentals.pdf (p225) [7] Senior notes: Ryan Ho Fluids and Nutrition.pdf (p7) [8] Senior notes: Ryan Ho Respiratory.pdf (p73, p81)
Diagnostic Criteria
Unlike a single disease entity (e.g., asthma with GINA criteria, or SLE with ACR/EULAR criteria), "recurrent chest infections" is a clinical presentation — a pattern that demands you find the underlying cause. Therefore, the diagnostic process has two distinct layers:
- Confirming the pattern itself — establishing that this truly is recurrent pneumonia
- Identifying the underlying aetiology — which is the real diagnosis
Definition (operational diagnostic criteria) [1]:
Recurrent pneumonia = ≥2 episodes of pneumonia in a single year OR ≥3 episodes at any time, with radiographic clearing between episodes.
Each individual episode must satisfy the criteria for pneumonia:
| Component | Criteria in Paediatrics | Why |
|---|---|---|
| Clinical | Fever + respiratory symptoms (cough, tachypnoea, respiratory distress) + signs of consolidation (focal crackles, dullness, bronchial breathing) | Pneumonia is a clinico-radiological diagnosis; clinical features alone are insufficiently specific in children |
| Radiological | New infiltrate / consolidation on CXR | A CXR should be considered in the presence of lower respiratory tract signs, relentlessly progressive cough, haemoptysis [4]; confirms parenchymal disease and distinguishes from URTI or asthma |
| Clearing | CXR must normalise between episodes | This is the critical criterion — it proves each episode is new rather than a single non-resolving infection |
Age-specific tachypnoea thresholds (WHO criteria — essential for paediatrics):
- < 2 months: RR > 60/min
- 2–12 months: RR > 50/min
- 1–5 years: RR > 40/min
5 years: RR > 20/min
Must-Know Distinction
Recurrent vs Non-resolving (persistent) pneumonia — these require DIFFERENT workups:
- Recurrent: CXR clears → think structural anomaly, immune deficiency, aspiration, ciliary dysfunction
- Non-resolving: CXR never clears → think foreign body with complete obstruction, TB, malignancy, congenital lung malformation, lung abscess, empyema
Layer 2: Diagnostic Criteria for Specific Underlying Causes
Once recurrent pneumonia is confirmed, the underlying cause must be identified. Key conditions have their own diagnostic criteria:
| Test | Diagnostic Criteria | Notes |
|---|---|---|
| Sweat test (gold standard) [1] | Sweat chloride > 60 mmol/L = diagnostic [1] | Procedure: pilocarpine iontophoresis → collect sweat → measure Cl⁻. Borderline: 30–59 mmol/L (requires repeat + genetic testing). Normal: < 30 mmol/L |
| Newborn screening [1] | ↑immunoreactive trypsinogen (IRT) → proceed to genetic test [1] | IRT is released from damaged pancreas; elevated in CF neonates |
| Genetic test [1] | Identification of two CFTR mutations | ~2000 gene mutations identified; Phe508del is the most frequent (~78%) in UK [1] |
Diagnosis requires consistent clinical features + evidence of CFTR dysfunction (elevated sweat Cl⁻ and/or 2 CFTR mutations).
| Test | Finding | Interpretation |
|---|---|---|
| Nasal NO screening [1] | ↓NO [1] ( < 77 nL/min) | High sensitivity screening test; low nasal NO because of chronic sinusitis and poor sinus ventilation |
| High-speed video microscopy (HSVM) | Abnormal ciliary beat pattern and/or frequency | Obtained from nasal epithelial cells via nose brush [1] |
| Transmission electron microscopy (TEM) | Ultrastructural defects (outer/inner dynein arm defects, central pair abnormalities) | Classic but ~30% of PCD patients have normal ultrastructure → TEM alone cannot exclude PCD |
| Genetic test [1] | Biallelic pathogenic variants in PCD-associated genes | > 50 genes identified; confirms diagnosis when found, but genetic testing cannot detect all cases |
PCD diagnosis typically requires clinical suspicion + low nasal NO + abnormal HSVM/TEM and/or confirmatory genetics. No single test is 100% sensitive.
There are no unified "diagnostic criteria" for all IEI, but the 10 warning signs [3] serve as a screening tool, and specific conditions have characteristic laboratory patterns:
| Condition | Key Diagnostic Investigations | Diagnostic Findings |
|---|---|---|
| XLA [1] | Flow cytometry for B cells; serum Ig levels; Btk gene sequencing | ↓B cells ( < 2%), pan-hypo(γ)globulinaemia [1]; absent Btk protein/gene mutation |
| CVID [1] | Serum Ig levels; vaccine responses; exclusion of other causes | ↓↓↓IgG, ↓IgA ± ↓IgE [1]; poor vaccine antibody responses; diagnosis of exclusion (age typically > 4 years) |
| SCID [1] | CBC with differential (absolute lymphocyte count); lymphocyte subsets; functional assays | ↓ALC ( < 2.5 × 10⁹/L in neonates); absent thymus shadow on CXR [1]; absent/very low T cells; absent proliferative response to mitogens |
| CGD [1] | Dihydrorhodamine (DHR) flow cytometry or nitroblue tetrazolium (NBT) test | Absent oxidative burst in neutrophils; DHR is more sensitive and quantitative than NBT |
| LAD [1] | Flow cytometry for CD18 (β₂ integrin) on neutrophils | Absent or markedly reduced CD18 expression [1]; ↑neutrophil count [1] |
| Complement deficiency [1] | CH50 (total haemolytic complement); AH50; individual complement levels | CH50 = 0 → classical pathway defect; AH50 = 0 → alternative pathway defect |
The following algorithm represents the systematic approach to a child presenting with recurrent chest infections:
Investigation Modalities — Detailed Guide
Tier 1: Every Child with Recurrent Chest Infections Should Get These
These are the baseline investigations that help you categorise the problem and direct further workup.
Why: The foundational investigation. It confirms pneumonia, identifies the anatomical pattern, and provides clues to the underlying cause.
| Finding | Interpretation | Points to |
|---|---|---|
| Consolidation — same lobe | Recurrent post-obstructive pneumonia | Foreign body, CPAM, sequestration, bronchial stenosis |
| Consolidation — different lobes | Systemic susceptibility | Immune deficiency, CF, PCD, aspiration |
| Cardiomegaly | Cardiothoracic ratio ≥0.5 (children) or ≥0.6 (infants) [9] | CHD with L→R shunt; note thymus in infants/young children simulates cardiomegaly → diagnostic difficulty [9] |
| Pulmonary plethora + cardiomegaly [9] | L-to-R shunt (e.g., VSD): volume overload [9] | Congenital heart disease |
| Absent thymic shadow (in an infant) | Absent thymus → SCID [1] | Combined immunodeficiency — the thymus should always be visible in neonates/young infants |
| Dextrocardia [9] | Situs inversus — when associated with left or central liver/stomach → likely only heart displaced [9] | PCD (Kartagener syndrome) if associated with sinusitis and bronchiectasis |
| Bronchiectasis signs | Ring shadows ( < 1cm = dilated bronchi end-on), tramline shadows (dilated bronchi side-on) [6] | CF, PCD, post-infectious, immune deficiency |
| Hyperinflation | Air trapping | Asthma, CF, foreign body (unilateral) |
| Hilar lymphadenopathy | Granulomatous disease | TB, sarcoidosis (rare in children) |
Paediatric CXR interpretation tip: Always look at the thymus (should be visible up to ~2 years), cardiac silhouette (using age-appropriate CTR), situs (stomach bubble, cardiac apex), and airway (tracheal position, bronchial anatomy).
CBC and differentials should be obtained [4].
| Finding | Interpretation | Points to |
|---|---|---|
| Neutrophilia | Acute bacterial infection; also seen in CGD (paradoxically) | Active pneumonia; if persistent neutrophilia with recurrent abscesses → consider LAD (↑neutrophils trapped in vasculature) |
| Lymphopenia (↓ALC) | SCID [1]; HIV; post-measles immune amnesia | Combined immunodeficiency — absolute lymphocyte count < 2.5 × 10⁹/L in infants is abnormal and warrants urgent lymphocyte subset analysis |
| Eosinophilia | Allergic/atopic disease; parasitic infection; ABPA; Hyper-IgE syndrome | Asthma; eosinophilic lung disease |
| Thrombocytopenia | Wiskott-Aldrich syndrome (characteristically small platelets on PBS); leukaemia | WAS: eczema + thrombocytopenia + immunodeficiency |
| Pancytopenia | Bone marrow failure or infiltration | Leukaemia; aplastic anaemia; advanced HIV |
| Normocytic anaemia | Anaemia of chronic disease; malignancy | Chronic infection; malignancy workup needed |
High Yield — Lymphocyte Count in Infants
Normal ALC in neonates and young infants is higher than in adults (4–13.5 × 10⁹/L). An ALC that looks "normal" by adult standards (e.g., 2.0 × 10⁹/L) may actually represent severe lymphopenia in an infant and should trigger urgent investigation for SCID.
Why: This is the single most important screening test for the most common category of PID — antibody deficiency (36.3% of all IEI) [1].
| Finding | Interpretation | Points to |
|---|---|---|
| Pan-hypogammaglobulinaemia (↓↓IgG, ↓IgA, ↓IgM) | XLA [1] (if absent B cells) or CVID | Present after 4–6 months due to maternal IgG depletion [1] — do NOT measure before 4–6 months as maternal IgG confounds |
| ↑IgM, ↓IgG/IgA/IgE [1] | Hyper-IgM syndrome [1] | Failure of class-switch recombination |
| Isolated ↓IgA | Selective IgA deficiency | Usually asymptomatic; most common PID |
| ↓↓↓IgG, ↓IgA/IgE [1] | CVID [1] | Must exclude secondary causes; typically diagnosed > 4 years |
| ↑↑IgE ( > 2000 IU/mL) | Hyper-IgE syndrome; ABPA; atopic disease | HIES: pneumatoceles, recurrent skin abscesses, retained primary teeth |
Age-specific reference ranges are essential: IgG levels are lowest at ~3–6 months (physiological nadir after maternal IgG wanes), and adult levels are not reached until ~7–8 years for IgG and even later for IgA (~adolescence). Always interpret against age-matched norms.
- Helpful in acute episodes to confirm active infection and monitor response
- Not useful for identifying the underlying cause
- Persistently elevated CRP/ESR between infections → consider chronic inflammation (bronchiectasis, TB, autoimmune disease, malignancy)
Tier 2: Directed by Tier 1 Results and Clinical Suspicion
| Investigation | What It Measures | Key Findings | When to Order |
|---|---|---|---|
| Lymphocyte subsets (flow cytometry: CD3, CD4, CD8, CD19, CD16/56) | Quantifies T cells, B cells, NK cells | ↓B cells → XLA [1]; ↓T cells → SCID/DiGeorge; ↓NK → some forms of SCID | Low Ig levels OR low ALC OR suspected combined ID |
| Vaccine antibody responses | Functional antibody production | Poor response to protein vaccines (tetanus, diphtheria) and polysaccharide vaccines (pneumococcal) → specific antibody deficiency | Normal total Ig but recurrent sinopulmonary infections (functional antibody deficiency) |
| DHR flow cytometry ("DHR burst test") | NADPH oxidase function in neutrophils | Absent oxidative burst → CGD | Recurrent deep organ/skin abscesses with catalase-positive organisms, BCG dissemination |
| CD18 expression (flow cytometry) | β₂ integrin on neutrophils | Absent or ↓CD18 → LAD [1] | Delayed cord separation, omphalitis, high neutrophil count with absent pus |
| CH50 and AH50 | Total haemolytic complement (classical and alternative pathways) | CH50 = 0 → defect in classical pathway (C1-C4); AH50 = 0 → alternative pathway defect; both = 0 → C3 or terminal pathway defect | Recurrent Neisseria infections; SLE-like illness + infections |
| HIV test | HIV antibody/antigen or PCR | Positive → secondary immunodeficiency | Any child with unexplained recurrent infections, especially with opportunistic organisms |
| Lymphocyte proliferation assays | T cell function (response to mitogens like PHA) | Absent proliferation → severe T cell dysfunction (SCID) | Suspected combined immunodeficiency |
| Investigation | What It Measures | Key Findings | When to Order |
|---|---|---|---|
| Sweat test [1] | Sweat chloride concentration | Cl⁻ > 60 mmol/L = CF [1]; 30–59 = borderline | Any child with recurrent chest infections + GI symptoms (steatorrhoea, FTT), nasal polyps, or chronic productive cough; should be done in all cases of unexplained bronchiectasis |
| CFTR genetic testing | CFTR mutations | Two pathogenic mutations = CF | Positive/borderline sweat test; newborn screening positive (↑IRT → genetic test) [1] |
| Faecal elastase | Pancreatic exocrine function | ↓faecal elastase → pancreatic exocrine insufficiency (seen in > 90% CF patients) [1] | Steatorrhoea, FTT, suspected CF |
| Nasal NO measurement [1] | Nasal nitric oxide concentration | ↓NO ( < 77 nL/min) → screening for PCD [1] | Chronic wet cough from infancy, chronic sinusitis, situs inversus, neonatal respiratory distress |
| Ciliary structure/function examination [1] | Ciliary beat pattern and ultrastructure | Abnormal beat pattern on HSVM; dynein arm defects on TEM | Low nasal NO or high clinical suspicion for PCD |
| PCD genetic panel | PCD-associated genes ( > 50 known) | Biallelic pathogenic variants confirm diagnosis | Supportive HSVM/TEM findings; inconclusive conventional tests |
| Investigation | What It Measures | Key Findings | When to Order |
|---|---|---|---|
| Video fluoroscopic swallow study (VFSS) | Dynamic assessment of swallowing phases | Aspiration or penetration during swallow; pooling in valleculae/piriform sinuses | Neurodevelopmental abnormality [4]; coughing/choking with feeds; recurrent aspiration pneumonia |
| Fibreoptic endoscopic evaluation of swallowing (FEES) | Direct visualisation of laryngeal function during swallowing | Aspiration, laryngeal cleft, vocal cord palsy | Alternative to VFSS; can be done at bedside |
| 24-hour pH/impedance monitoring | Quantifies acid and non-acid reflux episodes | Abnormal acid exposure time; correlation of reflux events with respiratory symptoms | Suspected GORD-related aspiration; especially when GORD is "silent" |
| Upper GI contrast study | Anatomy of oesophagus and stomach | H-type TOF (contrast entering trachea from oesophagus); malrotation; oesophageal stricture | Suspected TOF (especially H-type); anatomical assessment |
| Bronchoscopy with BAL | Airway inspection + bronchoalveolar lavage | Lipid-laden macrophages in BAL → chronic aspiration (lipid-laden macrophage index > 100 is suggestive) | Recurrent aspiration suspected but VFSS is negative; also useful to identify foreign body or airway anomaly |
| Investigation | What It Measures | Key Findings | When to Order |
|---|---|---|---|
| CT thorax [1] | Detailed lung parenchymal and airway anatomy | CPAM (cystic/solid mass); sequestration (anomalous vessel); bronchiectasis pattern; foreign body; mediastinal mass/lymphadenopathy | CT thorax and bronchoscopy for structural disease [1]; same-lobe recurrence; chronic symptoms |
| CT angiography | Vascular anatomy | Vascular ring/sling compressing airway; anomalous systemic arterial supply (sequestration) | Stridor + recurrent infections; suspected vascular compression |
| HRCT chest | High-resolution thin-section imaging of airways and parenchyma | HRCT showing bronchiectasis [3]; tramline shadows, signet ring sign (airway larger than adjacent vessel); mosaic attenuation (air trapping in PCD/obliterative bronchiolitis) | Chronic productive cough; suspected bronchiectasis; characterising established lung disease |
| Flexible bronchoscopy ± BAL [1] | Direct airway visualisation + sampling | Foreign body; endobronchial lesion; bronchomalacia; airway compression; BAL for microbiology (culture, AFB), cytology (lipid-laden macrophages), differential cell count | Bronchoscopy for structural disease [1]; same-lobe recurrence; unexplained chronic cough; suspected aspiration |
| Rigid bronchoscopy | Therapeutic airway intervention | Foreign body removal; dilatation of stenosis | Confirmed or highly suspected foreign body (definitive treatment) |
| Echocardiography | Cardiac structure and haemodynamics | L→R shunt (VSD, ASD, PDA); estimation of pulmonary artery pressure; conotruncal anomalies (DiGeorge) | Cardiac murmur; signs of heart failure; suspected CHD |
| Investigation | Key Findings | Notes |
|---|---|---|
| Tuberculin skin test (TST) / Mantoux | Induration ≥ 10mm (or ≥ 5mm if immunocompromised) | Tests delayed-type hypersensitivity to mycobacterial antigens; affected by BCG vaccination |
| Interferon-gamma release assay (IGRA) | Positive = active T cell response to TB-specific antigens | More specific than TST (not affected by BCG); less reliable in children < 5 years |
| Early morning gastric aspirate (EMGA) × 3 | AFB smear and culture; TB PCR | For children or uncooperative patients [8]; children rarely expectorate sputum — EMGA captures swallowed respiratory secretions |
| CXR | Hilar/mediastinal lymphadenopathy; consolidation; miliary pattern; cavitation (older children) | Primary TB in children often shows lymphadenopathy rather than cavitation |
| CT thorax | Better sensitivity for lymphadenopathy and early parenchymal disease | When CXR is equivocal |
| Investigation | Purpose | When |
|---|---|---|
| Whole-exome / whole-genome sequencing | Identify novel or rare genetic causes of IEI, PCD, CF | When clinical picture strongly suggests a genetic condition but standard panels are negative |
| Lung biopsy (open or thoracoscopic) | Histological diagnosis of interstitial lung disease, granulomatous disease, or unusual infections | When non-invasive workup is inconclusive and child continues to deteriorate |
| Bone marrow aspirate/trephine | Assess haematopoiesis; exclude malignancy or bone marrow failure | Pancytopenia; suspected leukaemia/lymphoma; evaluate for SCID pre-transplant |
| Cardiac catheterisation | Definitive haemodynamic assessment | Complex CHD; quantify shunt; pre-operative planning |
-
Start simple, escalate as needed: CXR → bloods → targeted second-line tests. Don't order everything at once.
-
Most children with cough due to a simple URI do not need any investigations [4]. Only investigate when features suggest something beyond a normal URTI.
-
Age-specific interpretation is crucial: Normal ALC, immunoglobulin levels, thymic shadow, and heart size all vary with age. Always use paediatric reference ranges.
-
Pattern recognition guides investigations:
- Same-lobe → CT thorax + bronchoscopy
- Different-lobe + sinopulmonary → immunoglobulins + sweat test + nasal NO
- Choking with feeds → VFSS
- Cardiac murmur + pulmonary plethora → echocardiography
-
Family-centred care: Explain the rationale for investigations to parents/caregivers. Many tests (sweat test, nasal NO) are non-invasive and can be done as outpatient. Genetic testing requires informed consent and genetic counselling.
-
Think about the child's wellbeing: Minimise blood draws (batch samples), use topical anaesthetics (EMLA cream), involve play therapists for procedures like bronchoscopy.
High Yield Summary — Diagnostic Approach
Layer 1 — Confirm recurrent pneumonia: ≥2/year or ≥3 ever with CXR clearing between episodes. Rule out frequent URTI or asthma with atelectasis mimicking pneumonia.
Layer 2 — Determine pattern: Same lobe → anatomical/local workup (CT, bronchoscopy). Different lobes → systemic workup (bloods, immunoglobulins, sweat test, nasal NO).
Tier 1 investigations (all patients): CXR, CBC with differential, serum Ig levels (IgG, IgA, IgM, IgE), inflammatory markers.
Tier 2 (directed by Tier 1):
- Immune deficiency → lymphocyte subsets, vaccine responses, DHR, CH50, HIV test
- Impaired clearance → sweat test (CF), nasal NO + HSVM/TEM (PCD)
- Aspiration → VFSS, pH/impedance, BAL for lipid-laden macrophages
- Structural → CT thorax, bronchoscopy, CT angiography, echocardiography
- TB → TST/IGRA, EMGA × 3, CT thorax
Key paediatric points: Use age-specific reference ranges for ALC and Ig levels. ALC < 2.5 × 10⁹/L in an infant is abnormal. Sweat test is gold standard for CF (Cl⁻ > 60 mmol/L). Nasal NO is the screening test for PCD. DHR flow cytometry is the test for CGD. Absent thymic shadow on CXR in an infant → think SCID.
Active Recall - Diagnosis of Recurrent Chest Infections
[1] Senior notes: Adrian Lui Pediatrics.pdf (p163, p167, p181, p182, p183, p406, p407, p410, p411) [3] Lecture slides: GC 144. A child with recurrent infections Primary immunodeficiencies.pdf (p6, p12, p28) [4] Lecture slides: GC 141. A child with cough acute and chronic cough in children.pdf (p14, p15, p20) [6] Senior notes: Ryan Ho Fundamentals.pdf (p221, p224, p225, p226) [8] Senior notes: Ryan Ho Respiratory.pdf (p67, p81, p129) [9] Senior notes: Adrian Lui Pediatrics.pdf (p198)
The management of recurrent chest infections in children has two fundamental components running in parallel:
- Acute management — Treating each individual infection episode effectively
- Definitive management — Identifying and treating the underlying cause to break the vicious cycle
The key insight is this: treating the acute infection alone is insufficient. If you don't find and address the reason why the child keeps getting infected, you're treating symptoms while the disease (and lung damage) progresses.
Acute Management of Each Infection Episode
Every episode of pneumonia in a child with recurrent chest infections requires appropriate acute treatment. The principles are the same as for any paediatric community-acquired pneumonia (CAP), with modifications based on the known underlying condition.
Supportive care is the mainstay of treatment [1].
| Measure | Rationale | Paediatric Specifics |
|---|---|---|
| Fluid support [1] | Higher fluid requirement due to fever, tachypnoea, reduced oral intake and vomiting [1]. Dehydration worsens mucus viscosity and impairs clearance | Oral fluids preferred; NG/IV if unable to maintain oral intake. Use Holliday-Segar for maintenance IV fluids (100 mL/kg/d for first 10 kg, 50 mL/kg/d for next 10 kg, 20 mL/kg/d thereafter). Avoid fluid overload — especially in CHD |
| Oxygen support [1] | Correct hypoxaemia from V/Q mismatch caused by consolidated lung | High flow O₂ ± CPAP, BiPAP [1]; target SpO₂ ≥ 92% (or ≥ 94% in infants < 6 months). Use nasal prongs for mild hypoxia, high-flow nasal cannula (HFNC) or CPAP for moderate respiratory distress |
| Antipyretics | Fever increases metabolic demand and fluid losses; comfort | Paracetamol 15 mg/kg Q4–6H (max 60 mg/kg/day) OR ibuprofen 5–10 mg/kg Q6–8H (if > 3 months, not dehydrated, no renal impairment) |
| Nutritional support | Sick children often eat poorly; malnutrition impairs immune function and respiratory muscle strength (muscle wasting → respiratory muscle weakness → resp failure and chest infections [7]) | Encourage small frequent feeds; NG feeding if needed; monitor weight |
| Chest physiotherapy | Help expectoration in patient suppressing cough because of pleural pain [1]; mobilise secretions | Particularly important in CF, PCD, and bronchiectasis; less evidence in uncomplicated pneumonia |
2. Antimicrobial Therapy for Acute Episodes
The choice of antibiotic depends on the child's age, severity, likely pathogen (which is influenced by the underlying condition), and local resistance patterns.
LRI pathogens: viral, bacterial (Streptococcus pneumoniae, Haemophilus influenzae, Pseudomonas if immunocompromised, Chlamydia if neonate) [4].
| Setting | Empirical Regimen | Paediatric Dosing | Rationale |
|---|---|---|---|
| Mild CAP, outpatient | PO amoxicillin (1st line) | 40–90 mg/kg/day in 2–3 divided doses × 5–7 days | Covers S. pneumoniae (most common bacterial cause); high-dose preferred if resistance suspected |
| Mild CAP, atypical suspected (school-age child) | PO macrolide (azithromycin or clarithromycin) | Azithromycin: 10 mg/kg Day 1, then 5 mg/kg Days 2–5; Clarithromycin: 7.5 mg/kg BD × 7–10 days | Covers Mycoplasma pneumoniae and Chlamydophila pneumoniae — more common in children > 5 years |
| Moderate CAP, inpatient | IV amoxicillin or IV ampicillin; add macrolide if atypical features | IV ampicillin 50 mg/kg Q6H | Step down to oral when clinically improving (afebrile 24–48H, tolerating oral) |
| Severe CAP, inpatient | IV co-amoxiclav (Augmentin) or IV ceftriaxone ± macrolide | IV co-amoxiclav 30 mg/kg Q8H; IV ceftriaxone 50 mg/kg once daily (max 2g) | Broader spectrum; ceftriaxone covers resistant pneumococcus and H. influenzae |
| Underlying Condition | Likely Pathogens | Preferred Empirical Therapy | Why |
|---|---|---|---|
| Cystic fibrosis | S. aureus, H. influenzae (early), P. aeruginosa, Burkholderia cepacia (late) [1] | Oral/IV antibiotics for respiratory infections [1]; anti-staphylococcal (flucloxacillin) + anti-pseudomonal (ciprofloxacin PO or IV piperacillin-tazobactam + tobramycin) based on sputum culture | CF airways are chronically colonised; always send sputum for culture and treat based on sensitivities. Burkholderia requires specialist input |
| Primary immunodeficiency | Encapsulated bacteria (Ab deficiency); opportunistic organisms (combined/T cell deficiency) | Broader spectrum + consider IV route; if combined ID → cover for PJP (co-trimoxazole), CMV (ganciclovir), fungi (fluconazole) | Need for intravenous antibiotics to clear infections [3] is a warning sign; immunocompromised children need more aggressive empirical cover |
| Aspiration | Oropharyngeal flora including anaerobes (Bacteroides, Fusobacterium), Streptococci, S. aureus | IV amoxicillin-clavulanate (Augmentin) or IV ampicillin-sulbactam (Unasyn); add metronidazole if suspect anaerobic component | Anaerobic coverage is essential for aspiration pneumonia; chemical pneumonitis from acid also needs treatment of superinfection |
| Bronchiectasis (established) | H. influenzae, Moraxella catarrhalis, S. aureus, P. aeruginosa | Sputum-guided therapy; empiric anti-pseudomonal if PsA colonised | Antibiotic therapy: generally recommend 10–14 days [8] for exacerbations |
Paediatric Antibiotic Prescribing — Key Principles
- Always use weight-based dosing — children are not small adults.
- Use paediatric formulations — suspensions/syrups for young children who cannot swallow tablets (e.g., amoxicillin suspension 125 mg/5 mL or 250 mg/5 mL).
- Step down from IV to oral early — when afebrile for 24–48H, tolerating oral, and clinically improving.
- Send cultures before antibiotics when possible — sputum (if old enough), nasopharyngeal aspirate, blood culture.
- De-escalate once sensitivities are known.
Arrange clinical review 6 weeks later [1]. CXR if persistent symptoms or suspect underlying malignancy [1].
- Resolution: Fever resolves in several days but CXR takes weeks to months to resolve [1]
- Delayed recovery → consider: complications (abscess, parapneumonic effusion), alternative diagnosis (ILD, TB), underlying cause (obstruction, recurrent aspiration) [1]
Definitive Management — Treating the Underlying Cause
This is where the real impact is made. The specific management depends entirely on the identified aetiology.
| Condition | Management | Details |
|---|---|---|
| Foreign body | Rigid bronchoscopy — therapeutic removal | This is a time-critical intervention. Rigid bronchoscopy allows both visualisation and extraction using optical forceps. Performed under general anaesthesia. Flexible bronchoscopy can diagnose but rigid is preferred for extraction (better airway control, larger instruments). Post-removal: short course antibiotics if secondary infection present |
| CPAM | Surgical resection (lobectomy/segmentectomy) | Even asymptomatic CPAMs are usually resected to prevent recurrent infection and (very small) malignancy risk (pleuropulmonary blastoma). Timing: usually elective at 3–6 months if asymptomatic; earlier if symptomatic/infected |
| Pulmonary sequestration | Surgical resection | Intralobar: lobectomy (shares pleura with normal lung); Extralobar: simple excision (has own pleural covering). Must identify and ligate the anomalous systemic arterial supply (from aorta) to prevent catastrophic haemorrhage |
| Vascular ring/sling | Surgical division/reimplantation | Division of the ring (e.g., double aortic arch → divide the smaller arch) or reimplantation of the anomalous vessel (e.g., pulmonary artery sling → reimplant LPA to main PA). Often requires cardiothoracic surgical expertise |
| Bronchial stenosis | Balloon bronchoplasty or surgical resection | Bronchoscopic balloon dilatation for short-segment stenosis; surgical resection and reanastomosis for longer segments; stenting rarely used in children due to growth |
| Extrinsic compression (TB lymphadenopathy) | Anti-TB therapy ± corticosteroids for airway compression | Standard 4-drug regimen (RHZE) modified for children (see TB section below); corticosteroids reduce inflammatory lymph node bulk |
B. Cystic Fibrosis — Comprehensive Management
CF management is multidisciplinary and requires a dedicated CF centre. The goal is to slow the vicious cycle of infection → inflammation → lung damage.
Avoid contact between CF patients [1] to prevent cross-infection.
| Modality | Details | Mechanism |
|---|---|---|
| Chest physiotherapy twice daily [1] | Postural drainage, controlled deep breathing exercise [1]; active cycle of breathing technique; positive expiratory pressure (PEP) devices; exercise | Gravity-assisted drainage + forced expiratory manoeuvres mobilise viscid mucus from airways |
| Nebulised mucolytics [1] | DNase (dornase alfa), hypertonic saline [1] | DNase: cleaves extracellular DNA in sputum (from dead neutrophils) → reduces viscosity. Hypertonic saline: osmotically draws water into airways → hydrates airway surface liquid → improves clearance |
| Bronchodilator [1] | Salbutamol nebulised before physiotherapy | Opens airways to allow better drainage of secretions; some CF patients have reactive airways |
| Oral/IV antibiotics for respiratory infections [1] | Culture-guided; anti-pseudomonal if PsA colonised | Treat acute exacerbations aggressively; chronic suppressive antibiotics (e.g., inhaled tobramycin alternating months) to reduce bacterial load |
| CFTR modulators [1] | Can be classified into 3 classes: potentiator, corrector, amplifier [1] |
CFTR potentiator, e.g., ivacaftor [1]: enables CFTR protein at cell surface to function more effectively as chloride channel [1]
CFTR corrector, e.g., lumacaftor, tezacaftor, elexacaftor [1]: helps CFTR protein fold correctly and get to cell surface [1]
Recent studies show that triple therapy of 2 correctors + 1 potentiator shows excellent results [1] — specifically elexacaftor/tezacaftor/ivacaftor (Trikafta/Kaftrio), which is effective for patients with at least one Phe508del allele (~90% of CF patients). This is a revolutionary advance — improves FEV₁ by ~14%, reduces pulmonary exacerbations by ~63%, and dramatically improves quality of life.
| Drug | Class | Indication |
|---|---|---|
| Ivacaftor | Potentiator | Gating mutations (e.g., G551D) — ages ≥ 4 months |
| Lumacaftor/ivacaftor | Corrector + potentiator | Phe508del homozygous — ages ≥ 2 years |
| Tezacaftor/ivacaftor | Corrector + potentiator | Phe508del homozygous or certain residual function mutations — ages ≥ 6 years |
| Elexacaftor/tezacaftor/ivacaftor | 2 correctors + 1 potentiator | At least 1 Phe508del allele — ages ≥ 2 years (extended 2024) |
Assess dietary status regularly [1]:
| Modality | Details |
|---|---|
| Pancreatic replacement therapy [1] | Oral enteric-coated (e.g., Creon) [1] — taken with all meals and snacks. Dose adjusted to stool output and fat content of meals |
| Fat-soluble vitamin supplementation [1] | Vitamin A/D/E/K [1] — because pancreatic insufficiency → fat malabsorption → deficiency of fat-soluble vitamins |
| High-calorie diet | CF patients need 120–150% of normal caloric intake due to increased metabolic demand from chronic infection + malabsorption |
| ± Nutritional supplementation ± gastrostomy feeding if additional calories required [1] | PEG/gastrostomy for severe FTT despite oral supplements |
| Complication | Screening | Management |
|---|---|---|
| CF-related diabetes (CFRD) [1] | ALL children > 10 years screened annually [1] with OGTT | Insulin [1] (not metformin — CFRD is primarily insulin-deficient) |
| Liver disease (33%) [1] | LFTs, USS abdomen | Ursodeoxycholic acid (↑bile flow) [1] |
| Infertility (~100% males) [1] | Counselling in adolescence | Absent vas deferens [1]; assisted reproduction may be possible |
| Nasal polyps, sinusitis [1] | Clinical assessment | Intranasal steroids ± polypectomy |
Management: as in other causes of bronchiectasis [1].
| Modality | Details | Rationale |
|---|---|---|
| Airway clearance | Chest physiotherapy ≥ twice daily; positive expiratory pressure devices; regular exercise | Compensate for absent mucociliary clearance with mechanical clearance techniques |
| Prompt antibiotic treatment of infections | Culture-guided; treat exacerbations for 10–14 days | Prevent progressive airway damage; PCD patients colonise with similar organisms to CF (H. influenzae, S. pneumoniae, later P. aeruginosa) |
| Long-term macrolide therapy | Azithromycin 3×/week for immunomodulatory effect | Reduces airway inflammation and exacerbation frequency (as in bronchiectasis management [8]) |
| ENT management | Hearing aids for conductive hearing loss (chronic OME); sinus surgery for refractory sinusitis | Chronic middle ear effusions from impaired mucociliary clearance in Eustachian tube |
| Avoid smoking / passive smoke | Environmental control | No cilia to compensate → any additional insult is devastating |
PCD vs CF Management — Similarities and Differences
Both require aggressive airway clearance and prompt antibiotic treatment of infections. Key differences: CF has CFTR modulators (game-changing), pancreatic replacement, and high-calorie diet needs. PCD has significant ENT disease requiring hearing aids and sinus surgery. Neither should use cough suppressants — the cough is the patient's only effective clearance mechanism.
| Treatment | Indication | Details | Contraindications/Cautions |
|---|---|---|---|
| IVIG replacement [3] | XLA (started on regular IVIG) [3]; CVID; Hyper-IgM syndrome; any significant antibody deficiency with recurrent infections | IVIG replacement in a group of Chinese boys with XLA [3] showed improved growth and reduced infections. Dose: 0.4–0.6 g/kg every 3–4 weeks IV (or subcutaneous Ig weekly as alternative). Target: trough IgG > 5–8 g/L | Urticaria after 1st dose IVIG [3] — pre-medicate with antihistamine and slow infusion rate; IgA-deficient patients with anti-IgA antibodies → use IgA-depleted products or subcutaneous route; avoid in heart failure (fluid volume) |
| Haematopoietic stem cell transplant (HSCT) | SCID (curative and urgent — mortality increases with delay); CGD (if severe/refractory); WAS; LAD; other severe PID | Only curative option for most severe PID. Donor: HLA-matched sibling (best), matched unrelated donor, haploidentical parent. Gene therapy now available for some SCID subtypes (ADA-SCID, X-SCID) | Pre-transplant conditioning carries risk of infection, organ toxicity. GvHD is a significant risk with mismatched donors |
| Prophylactic antimicrobials | All severe PID until definitive treatment | Co-trimoxazole (PJP prophylaxis); fluconazole/itraconazole (fungal prophylaxis); aciclovir (HSV/VZV prophylaxis in T cell deficiency). CGD: itraconazole + co-trimoxazole long-term | Check G6PD before co-trimoxazole; monitor LFTs with azoles |
| Interferon-gamma | CGD — as adjunct | Subcutaneous IFN-γ 3×/week reduces serious infections in CGD by ~70% | Flu-like symptoms common; not universally available |
| Avoid live vaccines | All significant PID (especially SCID, CGD, XLA) | BCG → SCID, CGD; OPV → SCID, XLA [1]. Live vaccines (BCG, OPV, rotavirus, MMR, varicella) can cause disseminated disease in immunodeficient children | Household contacts should receive inactivated vaccines when possible (IPV instead of OPV) |
| Gene therapy | ADA-SCID; X-linked SCID; some forms of CGD | Retroviral/lentiviral vector delivers corrected gene to patient's own stem cells; avoids GvHD risk | Still experimental for many conditions; risk of insertional mutagenesis (leukaemia) with older vectors |
SCID Is a Medical Emergency
SCID is fatal without treatment [1]. Once diagnosed (or strongly suspected — e.g., lymphopenic infant with severe infection and absent thymus), the child needs:
- Protective isolation (reverse barrier nursing)
- Irradiated, CMV-negative blood products (to prevent GvHD from donor lymphocytes and CMV transmission)
- PJP prophylaxis (co-trimoxazole)
- Antifungal prophylaxis (fluconazole)
- Urgent referral for HSCT — outcomes are significantly better if transplant occurs before 3.5 months of age or before the first serious infection
- Avoid live vaccines — these can be fatal
| Modality | Indication | Details |
|---|---|---|
| Feeding modification | Neurodevelopmental disorders with oropharyngeal dysphagia | Speech and language therapy (SLT) assessment; thickened feeds (reduce aspiration risk); altered positioning (upright 30–45° during and after feeds); small, frequent feeds |
| Anti-reflux measures | GORD-related aspiration | Positioning: head-up 30°; feed thickening; proton pump inhibitor (omeprazole 1 mg/kg/day, max 20 mg; or esomeprazole) to reduce acid injury to larynx/airway. Note: PPI does not reduce reflux volume, only acid content |
| Fundoplication (Nissen) | Severe GORD refractory to medical therapy; life-threatening aspiration events | Surgical wrap of gastric fundus around lower oesophagus to create a mechanical anti-reflux barrier. Consider if PPI + positioning + thickening fails and aspiration continues. In neurologically impaired children, often combined with gastrostomy |
| TOF/TEF repair | Tracheo-oesophageal fistula | Surgical division and closure of the fistula. H-type fistula may require cervical approach. Usually definitive |
| Laryngeal cleft repair | Laryngeal cleft (type 1–4) | Endoscopic injection laryngoplasty (type 1) or open surgical repair (types 2–4) |
| Salivary gland management | Severe sialorrhoea with aspiration of saliva (e.g., severe cerebral palsy) | Anticholinergics (glycopyrrolate 20–40 mcg/kg TDS); botulinum toxin injection into salivary glands; surgical options (salivary gland excision/duct ligation) |
Surgical closure if refractory to maximal medical treatment with refractory HF, FTT, recurrent chest infections [10].
| Step | Details |
|---|---|
| Medical management of heart failure | Diuretics (furosemide 1–2 mg/kg/day + spironolactone 1–2 mg/kg/day); ACE inhibitor (captopril 0.5–2 mg/kg/day TDS); high-calorie feeds (often concentrated formula or breast milk fortifier); NG feeding if needed |
| Surgical repair | Indications: refractory HF, FTT, recurrent chest infections; moderate/severe VSD with pulmonary hypertension (PAP > 50% systemic); persistent L-to-R shunt with LV dilatation (Qp:Qs > 2:1) [10]. Timing: usually at < 6 months [10]. Direct patch closure (1st line): low mortality ( < 1%) [10] |
| Contraindication to surgical closure | PAP suprasystemic or PVR > 12 WU → risk of precipitating acute RV HF + ↓LV output [10] (Eisenmenger physiology — the shunt has reversed) |
Why do L→R shunts cause recurrent chest infections? Excessive pulmonary blood flow → pulmonary vascular congestion → interstitial oedema → compression of small airways → impaired mucociliary clearance → recurrent LRTIs. Additionally, the increased pulmonary blood flow creates a "wet" lung environment that is hospitable to bacterial growth. Medical treatment of heart failure reduces pulmonary overcirculation, but definitive surgical repair is the cure.
Sometimes "recurrent pneumonia" may merely reflect frequent URTI or asthma [3].
| Step | Details |
|---|---|
| Confirm diagnosis | Ensure this is truly asthma (variable airflow obstruction, responsiveness to bronchodilators) and not another condition |
| Check compliance and technique | The most common cause of "poorly controlled asthma" is poor inhaler technique or non-adherence. Teach and re-teach using age-appropriate devices (MDI + spacer ± mask for < 5 years; DPI for older children) |
| Step up therapy (GINA stepwise approach for children 6–11 years) | Step 1: as-needed low-dose ICS-formoterol; Step 2: daily low-dose ICS; Step 3: low-dose ICS-LABA or medium-dose ICS; Step 4: medium-dose ICS-LABA ± LTRA; Step 5: high-dose ICS-LABA ± add-on (tiotropium, anti-IgE, anti-IL5) |
| Address triggers | Environmental control (house dust mite reduction, avoid tobacco smoke, manage allergic rhinitis) |
| Follow up | Regular review (3-monthly when adjusting); monitor with symptom scores (C-ACT), lung function (spirometry/PEF in cooperating children) |
| Phase | Regimen (Paediatric) | Duration | Notes |
|---|---|---|---|
| Intensive | Isoniazid (H) + Rifampicin (R) + Pyrazinamide (Z) + Ethambutol (E) | 2 months | Dosing: H 10 mg/kg (max 300 mg), R 15 mg/kg (max 600 mg), Z 35 mg/kg (max 2g), E 20 mg/kg (max 1g). Pyridoxine (vitamin B6) supplementation with isoniazid to prevent peripheral neuropathy |
| Continuation | Isoniazid + Rifampicin | 4 months | Total: 6 months for drug-susceptible pulmonary TB |
| Lymph node compression of airway | Add corticosteroids (prednisolone 1–2 mg/kg/day × 4 weeks, then taper) | With anti-TB therapy | Reduces inflammatory bulk of lymph nodes compressing bronchi |
Regardless of the specific aetiology, children with recurrent chest infections require:
| Domain | Action |
|---|---|
| Regular follow-up | Respiratory clinic review every 3–6 months; more frequent if severe disease |
| Growth monitoring | Plot height, weight, BMI on growth charts at every visit — FTT is a red flag for disease progression |
| Vaccination | Annual influenza vaccine; pneumococcal vaccine (PCV13 + PPSV23); pertussis booster; avoid live vaccines in immunodeficiency |
| Nutritional optimisation | Dietitian input; high-calorie diet if needed; supplementation (iron, zinc, vitamin D) |
| Psychosocial support | Chronic illness impacts the child and family; school liaison; psychological support; patient support groups (CF Trust, PCD Family Support Group) |
| Transition planning | For adolescents with chronic conditions (CF, PCD, PID) — plan transfer to adult services |
| Lung function monitoring | Spirometry when cooperating (usually ≥ 6 years); track FEV₁ decline over time |
| Sputum surveillance | Regular sputum cultures (especially CF) to detect new colonisation (e.g., P. aeruginosa) early and attempt eradication |
| Aetiology | Key Definitive Management |
|---|---|
| Foreign body | Rigid bronchoscopy for removal |
| CPAM / Sequestration | Surgical resection |
| Vascular ring | Surgical division/repair |
| Cystic fibrosis | CFTR modulators (Trikafta) + chest PT + mucolytics + pancreatic enzyme replacement + antibiotics + nutritional support |
| Primary ciliary dyskinesia | Chest PT + prompt antibiotics + macrolide prophylaxis + ENT management |
| Antibody deficiency (XLA, CVID) | IVIG replacement + prophylactic antibiotics |
| SCID | Urgent HSCT + protective isolation + antimicrobial prophylaxis + avoid live vaccines |
| CGD | Prophylactic itraconazole + co-trimoxazole + IFN-γ; HSCT if severe |
| Aspiration | Feeding modification + anti-reflux therapy ± fundoplication/surgical repair |
| CHD with L→R shunt | Medical HF treatment → surgical closure of defect |
| Poorly controlled asthma | Step up asthma therapy + compliance/technique review |
| TB | Standard anti-TB regimen (RHZE/RH) ± corticosteroids |
High Yield Summary — Management
Dual approach: Treat each acute infection (supportive care + antibiotics) AND identify and treat the underlying cause.
Acute management: Supportive (fluids, O₂, nutrition) + empirical antibiotics (amoxicillin 1st line for uncomplicated paediatric CAP; broader cover for immunocompromised or CF).
Definitive management by cause:
- Structural → Surgery (FB removal, CPAM resection, vascular ring repair)
- CF → CFTR modulators (elexacaftor/tezacaftor/ivacaftor = Trikafta — revolutionary for ≥1 Phe508del allele) + chest PT + DNase + pancreatic enzymes + vitamins ADEK
- PCD → Chest PT + prompt antibiotics + macrolide prophylaxis + ENT support
- Antibody deficiency → Regular IVIG (XLA, CVID); target trough IgG > 5–8 g/L
- SCID → Medical emergency → protective isolation + irradiated blood products + antimicrobial prophylaxis + urgent HSCT. Avoid live vaccines.
- CGD → Prophylactic itraconazole + co-trimoxazole + IFN-γ; consider HSCT
- Aspiration → SLT assessment + feed thickening + positioning + PPI ± fundoplication
- CHD → Medical HF management → surgical repair if refractory HF/FTT/recurrent infections (VSD patch closure at < 6 months)
- Asthma → Check compliance/technique first; step up GINA therapy
Key paediatric points: Weight-based dosing always. Use paediatric formulations (suspensions). Avoid live vaccines in immunodeficiency. SCID is a medical emergency — transplant before 3.5 months has best outcomes.
Active Recall - Management of Recurrent Chest Infections
[1] Senior notes: Adrian Lui Pediatrics.pdf (p163, p167, p181, p182, p183, p406, p407, p410, p411) [3] Lecture slides: GC 144. A child with recurrent infections Primary immunodeficiencies.pdf (p3, p4, p12, p28) [4] Lecture slides: GC 141. A child with cough acute and chronic cough in children.pdf (p11, p15) [7] Senior notes: Ryan Ho Fluids and Nutrition.pdf (p7) [8] Senior notes: Ryan Ho Respiratory.pdf (p67, p131, p132, p133) [10] Senior notes: Ryan Ho Cardiology.pdf (p194)
Complications of Recurrent Chest Infections in Children
The complications of recurrent chest infections fall into two broad categories:
- Acute complications — arising from each individual infection episode
- Chronic/long-term complications — the cumulative consequence of repeated pulmonary insults over time
Understanding complications requires appreciating that every episode of pneumonia causes some degree of airway and parenchymal inflammation. In a normal child with a single pneumonia, this heals completely. But in a child with recurrent infections, the inflammation is repetitive and cumulative — and eventually, the repair mechanisms are overwhelmed, leading to irreversible structural and functional damage.
A. Acute Complications of Individual Infection Episodes
These are the complications that can occur during any episode of pneumonia, but are more common and more severe in children with recurrent infections because:
- The underlying condition impairs host defences
- There may be pre-existing lung damage reducing physiological reserve
- Pathogens may be more virulent or resistant (especially in CF, immunodeficiency)
Pathophysiology: Consolidation → alveolar flooding with pus and inflammatory exudate → V/Q mismatch (perfusion of non-ventilated lung units) → hypoxaemia. If severe and widespread, CO₂ clearance also fails → hypercapnia (Type 2 respiratory failure).
Respiratory failure [1][5] is the most immediately life-threatening complication.
| Type | Mechanism | Blood Gas | Management |
|---|---|---|---|
| Type 1 (hypoxaemic) | V/Q mismatch from consolidated lung; intrapulmonary shunting | ↓PaO₂, normal or ↓PaCO₂ (compensatory hyperventilation) | Supplemental O₂ → HFNC → CPAP/BiPAP → intubation + IPPV if refractory |
| Type 2 (hypercapnic) | Respiratory muscle fatigue (especially in malnourished, neuromuscular disease); extensive bilateral disease | ↓PaO₂, ↑PaCO₂ | Non-invasive ventilation (BiPAP) → intubation + IPPV; avoid excessive O₂ in chronic retainers |
Paediatric physiology matters here: Infants have a higher metabolic rate and O₂ consumption per kg, smaller FRC relative to tidal volume, and more compliant chest wall — meaning they desaturate faster than adults and have less respiratory reserve. Respiratory failure can develop rapidly in a sick infant.
Parapneumonic effusion ± empyema thoracis [1][5]
Pathophysiology: This evolves through three stages:
| Stage | What Happens | Pathology | Clinical/Radiological Finding |
|---|---|---|---|
| Exudative (simple parapneumonic effusion) | Inflammation of visceral pleura adjacent to consolidated lung → ↑capillary permeability → sterile exudative fluid leaks into pleural space | Thin, free-flowing fluid; pH > 7.2, glucose > 2.2 mmol/L, LDH < 1000 | Blunted costophrenic angle; meniscus sign on CXR; responds to antibiotics alone |
| Fibrinopurulent (complicated parapneumonic effusion) | Bacteria invade the pleural space → neutrophil influx → fibrin deposition → loculations form | Turbid fluid; pH < 7.2, glucose < 2.2 mmol/L, LDH > 1000; may be culture-positive | Loculated effusion on USS; requires drainage (chest drain ± fibrinolytics) |
| Organising (empyema) | Fibroblasts invade → thick fibrous peel encases the lung ("pleural peel") → trapped lung | Pus in the pleural space; thick rind on imaging | Requires surgical decortication (thoracoscopic debridement, VATS) if fails to respond to drainage |
Why is empyema more common in recurrent chest infections? Children with immune deficiency, CF, or aspiration have impaired bacterial clearance, allowing organisms more time to invade the pleural space. In CF, virulent organisms like S. aureus and P. aeruginosa increase empyema risk. In immunodeficiency, the child cannot mount an adequate inflammatory response to contain infection within the lung parenchyma.
Paediatric management of empyema:
- Small, simple effusion → antibiotics alone, observe
- Moderate/large or complicated → chest drain insertion (pigtail catheter, USS-guided) + intrapleural fibrinolytics (urokinase or alteplase) to break down loculations
- Failed drainage or thick empyema → VATS (video-assisted thoracoscopic surgery) debridement
- Open thoracotomy with decortication is rarely needed in the modern era
Pathophysiology: Necrosis of lung parenchyma by particularly virulent or destructive organisms creates a cavity filled with pus. The abscess wall consists of granulation tissue and fibrosis.
| Risk Factors | Common Organisms | Clinical Features |
|---|---|---|
| Aspiration (neurodevelopmental disorders); immunodeficiency; post-obstructive infection (foreign body); CF | Anaerobes (Bacteroides, Fusobacterium); S. aureus; Klebsiella; P. aeruginosa; fungi (Aspergillus in immunocompromised) | Swinging fever despite appropriate antibiotics; foul-smelling sputum; CXR/CT showing thick-walled cavity ± air-fluid level |
Management: Prolonged IV antibiotics (4–6 weeks); percutaneous drainage if large ( > 4 cm) or not responding; surgical resection rarely needed in children.
Septicaemia with multi-organ failure [1][5]
Pathophysiology: Bacteria enter the bloodstream from the infected lung → systemic inflammatory response syndrome (SIRS) → if uncontrolled, progresses to sepsis → septic shock → multi-organ dysfunction syndrome (MODS).
In children, septic shock often manifests differently from adults:
- "Warm shock" (vasodilatory) is less common in children
- "Cold shock" (vasoconstricted, poor perfusion) is the classic paediatric pattern → cool extremities, prolonged capillary refill, weak pulses, tachycardia → often mistaken for dehydration
- Fluid-refractory shock → requires inotropes (adrenaline for cold shock, noradrenaline for warm shock)
Why are children with recurrent infections at higher risk of sepsis? Impaired immune function (whether from PID, malnutrition, or immunosuppressants) means the child cannot contain the infection locally. Additionally, repeated infections may have selected for more virulent or resistant organisms that are harder to treat.
Electrolyte abnormalities, e.g., hypoNa due to SIADH [1][5]
Pathophysiology of SIADH in pneumonia: Pulmonary inflammation → inappropriate release of ADH (vasopressin) from the posterior pituitary. ADH acts on V₂ receptors in the collecting duct → insertion of aquaporin-2 channels → ↑free water reabsorption → dilutional hyponatraemia.
- Clinical features: Serum Na < 135 mmol/L (can be < 125 in severe cases); concentrated urine (urine osmolality > serum osmolality); euvolaemic; urine Na > 40 mmol/L
- Management: Fluid restriction (60–75% of maintenance); treat the underlying infection; severe symptomatic hyponatraemia (seizures) → hypertonic saline 3% (2 mL/kg bolus)
B. Chronic / Long-Term Complications
These are the consequences of cumulative lung damage from repeated episodes of infection and inflammation. The central concept is Cole's "vicious cycle" — each infection causes more damage, which impairs clearance, which promotes more infection.
Bronchiectasis ("bronch-" = bronchi, "-ectasis" = dilatation) is pathological, irreversible dilatation of the bronchial airways [8].
Pathogenesis: vicious cycle of [8]:
- Obstruction: ↓mucus drainage → chronic infection [8]
- Infection: inflammation resulting in ↑mucus production, destruction of bronchial tissues and cartilage with fibrosis [8]
- Bronchial dilatation: inspiratory negative pressure pulls on bronchi → dilatation → further ↓mucus clearance → ↑obstruction [8]
This is the most important long-term complication of recurrent chest infections in children — it is what we are trying to prevent by identifying and treating the underlying cause early.
| Feature | Explanation |
|---|---|
| Chronic productive cough | Permanently dilated airways cannot clear secretions effectively → chronic bacterial colonisation → daily sputum production |
| Recurrent exacerbations | Colonised, damaged airways are vulnerable to acute bacterial overgrowth triggered by viral infections or environmental factors |
| Digital clubbing [4] | Chronic suppurative lung disease [4] — mechanism involves megakaryocyte fragments and PDGF release in the nail bed |
| Chest wall deformity [4] | Chronic airway or parenchymal disease [4] — chronic hyperinflation moulds the compliant paediatric thorax |
| Haemoptysis | Chronic inflammation stimulates hypertrophy of bronchial arteries (systemic pressure); these fragile, tortuous vessels can erode and bleed [6] |
| Progressive airflow obstruction | Airway wall destruction + peribronchial fibrosis → fixed airway narrowing → declining FEV₁ over time |
HRCT showing bronchiectasis [3] — as demonstrated in the case of a 3-year-old boy with XLA who had recurrent sinopulmonary infections [3]. This illustrates that bronchiectasis can develop even in very young children if the underlying immunodeficiency is not diagnosed and treated promptly.
Bronchiectasis in the context of specific underlying conditions:
| Condition | Typical Pattern | Why |
|---|---|---|
| CF | Upper lobe predominant; proximal (with ABPA) | Upper lobes affected early in CF; ABPA causes proximal bronchiectasis due to intense local inflammation |
| PCD | Lower lobe predominant | Gravity-dependent mucus stasis with impaired ciliary clearance; also middle lobe/lingula |
| Antibody deficiency | Lower lobe predominant | Lower lobes receive most ventilation and therefore most pathogen exposure; impaired antibody-mediated defence |
| Post-infectious (e.g., adenovirus, measles, pertussis) | Focal, often lower lobe | Some may have permanent damage (e.g., bronchiolitis obliterans) after adenovirus infection [1]; localised severe inflammation destroys that segment |
| Aspiration | Lower lobe (especially RLL) | Gravity-dependent aspiration |
Pathophysiology: Progressive bronchiectasis → extensive airway destruction → airflow obstruction + V/Q mismatch → chronic hypoxaemia → pulmonary vasoconstriction (hypoxic pulmonary vasoconstriction, HPV — an adaptive response that diverts blood away from poorly ventilated areas, but when global, it increases pulmonary vascular resistance) → pulmonary hypertension → right ventricular hypertrophy → cor pulmonale (right heart failure).
| Stage | Clinical Features |
|---|---|
| Chronic hypoxaemia | Exercise intolerance, fatigue, central cyanosis |
| Pulmonary hypertension | Loud P2, right parasternal heave, functional TR murmur |
| Cor pulmonale | Hepatomegaly, peripheral oedema, elevated JVP (difficult to assess in infants), ascites |
Why does cor pulmonale matter in paediatrics? It indicates end-stage lung disease — by this point, the damage is extensive and largely irreversible. This underscores the importance of early diagnosis and treatment of the underlying cause to prevent progression to this stage. In CF, cor pulmonale is a late and ominous sign associated with poor prognosis.
Failure to thrive [3][4] — serious systemic including pulmonary illness [4].
Pathophysiology — a multifactorial insult:
- ↑Energy expenditure: Chronic inflammation and infection increase basal metabolic rate; increased work of breathing consumes additional calories
- ↓Caloric intake: Sick children eat poorly; dyspnoea and cough interfere with feeding; chronic illness causes anorexia
- Malabsorption (specific to CF): Pancreatic exocrine insufficiency → fat and protein malabsorption → steatorrhoea → caloric and micronutrient losses
- Chronic hypoxia: Reduces growth hormone sensitivity and cellular metabolism
- Recurrent hospitalisations: Disrupted feeding routines, emotional stress
Growth failure is both a consequence and a perpetuator of recurrent infections — malnutrition impairs immune function (muscle wasting → respiratory muscle weakness → resp failure and chest infections [7]), creating another vicious cycle. This is why nutritional support is a critical component of management.
When recurrent chest infections are caused by congenital heart disease with L→R shunt, the long-term complication of the untreated shunt is Eisenmenger syndrome [10].
Eisenmenger syndrome: triad of (1) congenital L-to-R shunt (2) pulmonary arterial disease (3) cyanosis [10].
Mechanism: large unrepaired L-to-R shunt → destruction of pulmonary arterioles → irreversible pulmonary vascular disease with ↑PVR and pulmonary hypertension → eventual equalisation of pressure → reversal of shunt resulting in systemic hypoxia (cyanosis) [10].
Complications of Eisenmenger syndrome [10]:
- Cardiac: progressive right heart failure, arrhythmia, IE (rare)
- Pulmonary: pulmonary artery thrombosis, massive haemoptysis due to rupture of major vessel
- Systemic: stunted growth from hypoxia, polycythaemia, cerebral embolism/abscess
- Prognosis: 30–40% 10-year mortality with mean age of death at 37 years if transplant not done [10]
Why is this relevant to recurrent chest infections? If a child with a VSD presents with recurrent chest infections (from pulmonary overcirculation), and the diagnosis is missed or repair is delayed, the progressive pulmonary vascular damage will eventually make the defect inoperable (C/I: PAP suprasystemic or PVR > 12 WU [10]). This is why timely surgical closure (usually at < 6 months [10]) is critical.
These are often underappreciated but profoundly impact the child and family.
| Complication | Mechanism | Management |
|---|---|---|
| School absenteeism | Repeated hospitalisations and prolonged recovery periods | Hospital-based teaching; school liaison; home tutoring during prolonged illness |
| Developmental delay | Chronic hypoxia affects brain development; recurrent illness reduces engagement with learning; hospitalisations disrupt normal social development | Developmental assessment; early intervention services; educational psychology input |
| Anxiety and depression (child and caregivers) | Chronic illness burden; fear of next infection; body image (clubbing, chest deformity); parental guilt and exhaustion | Child psychology/psychiatry referral; peer support groups; family therapy |
| Impaired exercise tolerance | Chronic lung disease + deconditioning + malnutrition | Pulmonary rehabilitation (adapted for children); encourage safe physical activity |
| Treatment burden | Multiple medications, daily physiotherapy, frequent hospital visits — especially in CF and PCD | Simplify regimens where possible; adherence support; transition planning for adolescents |
| Condition | Unique Complications | Why |
|---|---|---|
| CF | CF-related diabetes (CFRD); liver disease (biliary cirrhosis); male infertility (absent vas deferens); pneumothorax; massive haemoptysis; nasal polyps; rectal prolapse (from chronic cough) | Multi-organ disease from CFTR dysfunction in epithelial cells throughout the body |
| PCD | Chronic otitis media → conductive hearing loss; subfertility (males — immotile sperm; females — impaired ciliary function in fallopian tubes) | Cilia are present in the middle ear, sinuses, fallopian tubes, and vas deferens |
| Primary immunodeficiency | Autoinflammation, autoimmunity, e.g., IBD, AIHA, arthritis [3]; non-malignant lymphoproliferation [3]; cancer, e.g., lymphoma [3] | Immune dysregulation → autoimmunity; impaired tumour surveillance → malignancy |
| Aspiration | Chemical pneumonitis → lung fibrosis; rectal/oesophageal strictures from chronic acid exposure; Barrett's oesophagus (rare in children) | Chronic acid injury to airway and oesophageal mucosa |
| Treatment | Complication | Why |
|---|---|---|
| Repeated antibiotic courses | Antimicrobial resistance; Clostridioides difficile infection; disruption of gut microbiome | Selective pressure on flora; loss of colonisation resistance |
| Corticosteroids (asthma, post-transplant) | Growth suppression; adrenal suppression; osteoporosis; immunosuppression → more infections | Cortisol inhibits the growth plate, suppresses the HPA axis, reduces bone formation, and impairs immune function |
| IVIG | Urticaria after 1st dose IVIG [3]; headache; aseptic meningitis; anaphylaxis in IgA-deficient patients with anti-IgA antibodies; fluid overload | Immune complex formation; foreign protein reaction; volume load |
| Aminoglycosides (in CF, bronchiectasis) | Ototoxicity (irreversible sensorineural hearing loss); nephrotoxicity | Accumulation in inner ear hair cells and renal tubular cells; concentration-dependent toxicity |
| Chronic azithromycin | QTc prolongation; hepatotoxicity; hearing impairment; selection for macrolide-resistant NTM | Direct cardiac ion channel effects; hepatic metabolism |
| Timeframe | Complication | Pathophysiology |
|---|---|---|
| Acute | Respiratory failure | V/Q mismatch, respiratory muscle fatigue |
| Acute | Parapneumonic effusion / empyema | Pleural inflammation → bacterial invasion → loculation → fibrous peel |
| Acute | Lung abscess | Parenchymal necrosis by virulent organisms |
| Acute | Septicaemia / multi-organ failure | Bacteraemia → SIRS → sepsis → MODS |
| Acute | Hyponatraemia (SIADH) | Inappropriate ADH release → dilutional hyponatraemia |
| Chronic | Bronchiectasis | Vicious cycle of obstruction → infection → inflammation → airway destruction → dilatation |
| Chronic | Chronic respiratory failure / cor pulmonale | Progressive airflow obstruction → hypoxia → pulmonary vasoconstriction → pulmonary HTN → RV failure |
| Chronic | Growth failure / FTT | ↑metabolic demand + ↓intake + malabsorption + chronic hypoxia |
| Chronic | Eisenmenger syndrome (CHD) | Unrepaired L→R shunt → irreversible pulmonary vascular disease → shunt reversal |
| Chronic | Psychosocial / developmental impact | Chronic illness burden, school absence, chronic hypoxia |
| Chronic | Condition-specific complications | CF: CFRD, liver disease, infertility; PCD: hearing loss, subfertility; PID: autoimmunity, malignancy |
| Chronic | Iatrogenic | Antibiotic resistance; steroid side effects; aminoglycoside toxicity; IVIG reactions |
High Yield Summary — Complications
Acute complications of each episode: Respiratory failure, parapneumonic effusion/empyema, lung abscess, septicaemia with multi-organ failure, hyponatraemia (SIADH).
The cardinal chronic complication is BRONCHIECTASIS — irreversible bronchial dilatation from the vicious cycle of obstruction → infection → inflammation → airway destruction. Once established, it is irreversible. This is what we aim to PREVENT by early diagnosis and treatment of the underlying cause.
Other chronic complications: Chronic respiratory failure → pulmonary hypertension → cor pulmonale; growth failure/FTT (both consequence and perpetuator of recurrent infections); Eisenmenger syndrome (if CHD is left untreated); psychosocial and developmental impact; iatrogenic complications from treatment.
Condition-specific complications: CF → CFRD, liver disease, male infertility; PCD → hearing loss, subfertility; PID → autoimmunity, lymphoma; CHD → Eisenmenger syndrome.
Key take-home message: Every episode of chest infection causes some airway damage. The urgency in managing recurrent chest infections is not just about treating the current episode — it is about breaking the vicious cycle before irreversible bronchiectasis develops.
Active Recall - Complications of Recurrent Chest Infections
References
[1] Senior notes: Adrian Lui Pediatrics.pdf (p163, p167) [3] Lecture slides: GC 144. A child with recurrent infections Primary immunodeficiencies.pdf (p3, p6, p12, p28) [4] Lecture slides: GC 141. A child with cough acute and chronic cough in children.pdf (p20) [5] Senior notes: Ryan Ho Respiratory.pdf (p65, p67) [6] Senior notes: Ryan Ho Fundamentals.pdf (p225) [7] Senior notes: Ryan Ho Fluids and Nutrition.pdf (p7) [8] Senior notes: Ryan Ho Respiratory.pdf (p128, p129) [10] Senior notes: Ryan Ho Cardiology.pdf (p186, p194)
Pulmonary Stenosis
Pulmonary stenosis is a congenital heart defect, most commonly diagnosed in neonates and children, in which narrowing of the pulmonary valve or outflow tract obstructs blood flow from the right ventricle to the pulmonary artery, leading to right ventricular pressure overload.
Syncope / Dizziness
Syncope is a transient loss of consciousness due to cerebral hypoperfusion, and dizziness is a sensation of unsteadiness or lightheadedness, which in children and adolescents most commonly results from vasovagal mechanisms, orthostatic intolerance, or benign paroxysmal vertigo of childhood.